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ABSTRACT 
 
Shiliang Wang: Dissecting the Genetic Architecture of Complex Traits: Hot Spots 
and Vascular Collaterals 
(Under the direction of Dr. James Faber) 
 
 Collateral arteries are endogenous “bypass vessels” that minimize tissue injury 
during arterial obstruction.  Recent studies from our laboratory demonstrate that wide 
variation exists among individuals in the extent (number and diameter) of native (pre-
existing) collaterals in healthy tissue and their outward remodeling (increase in anatomic 
diameter) in obstructive disease.  Evidence suggests this variation contributes 
importantly to the wide variation in thromboembolic stroke, ischemic heart disease and 
peripheral arterial disease in humans.  We hypothesized that genetic components 
contribute significantly to this variation.  We tested this hypothesis in 243 C57BL/6 X 
BALB/c (CXB) F2 mice, wherein number and diameter of native cerebral collaterals and 
collateral remodeling after middle cerebral artery occlusion (MCAO) were measured.  
Linkage analysis identified a major QTL on chromosome 7 (Canq1) responsible for more 
than 30% of the variation in collateral extent.  Three additional QTL were obtained for 
collateral number.  Analysis of chromosome substitution and CXB recombinant inbred 
strains confirmed the dominant role of the Canq1 locus.  We also identified a QTL on 
chromosome 11 linked to variation in collateral remodeling.  Efficient mix model 
association mapping (EMMA) of collateral number among 15 inbred strains delineated 
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172k (p=0.00002) and 290k (p=0.0004) base-pair regions containing 2 and 7 candidate 
genes, respectively, within Canq1.  Analysis of six additional inbred strains, chosen 
according to their haplotype within the 172 kb EMMA region, strengthened and narrowed 
the locus from 172 kb interval to 2 kb.  In candidate gene analyses, we found that 
collateral extent, infarct volume after MCAO, bleeding and re-bleeding times did not 
differ between Itgal-/,-IL4-/- or IL4-receptor-α-/- and wildtype mice.  mRNA expression of 
120 genes within the 95% confidence interval of Canq1, measured in the pial 
vasculature of C57BL/6 and BALB/c at embryonic day-14.5, -16.5 and -18.5 when the 
collateral circulation forms, identified 19 differentially expressed genes. 
 These results demonstrate that native collateral extent and collateral 
remodeling are heritable complex traits, with a highly significant QTL on chromosome 7 
governing the majority of the variation in these traits.  Furthermore, my work prioritizes a 
set of genes for future analysis as candidates underlying the process of collateral 
formation and its variation among individuals.  
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 Occlusive vascular diseases (eg, atherosclerosis of arteries supplying the heart, 
brain and lower extremities; thrombosis, stroke, and ischemic heart disease) are the 
leading cause of morbidity and mortality in the developed countries1.  Upon occlusion of 
an artery, many physiological pathways are recruited to lessen the severity of ischemic 
tissue injury.  Among these, three vascular anatomic protective mechanisms have been 
increasingly recognized: (1) the extent (i.e., number and diameter) of native (pre-
existing) collaterals, i.e., arteriole-to-arteriole anastomoses present in a healthy tissue 
before the onset of disease2, 3; (2) enlargement of lumen diameter and wall thickness of 
these collaterals, a process termed collateral remodeling or arteriogenesis that is 
initiated by increased shear stress4-8; and (3) ischemia-induced  angiogenesis consisting 
of sprouting of new capillaries from existing ones9.  Since it has become recognized that 
angiogenesis can only improve the distribution for whatever blood flow is supplied by the 
collaterals after artery occlusion, attention has focused on arteriogenesis in the past 
twenty years1, 4.  Arteriogenesis, which requires days-to-weeks to achieve up to an 
approximately 10-fold increase in collateral diameter depending on tissue and species, is 
induced by flow-dependent shear stress across the native collaterals when one arterial 
tree becomes occluded1, 10, 11.   
It has long been known that the severity of ischemic injury varies substantially 
among individuals and species12-15.  Given the major role played by collaterals in 
restoration of blood flow after occlusion, this variation likely depends in large part on 
variation in native collateral extent and the amount of collateral remodeling3.  A previous 
study from our laboratory reported that marked differences exist in native collateral 
extent, collateral remodeling, and tissue injury between C57BL/6 and BALB/c mouse 
strains after acute artery occlusion16.  Based on this study, two subsequent studies 
identified genetic loci (QTL) associated with variation in ischemic tissue injury in these 
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same strains17, 18.  However, the potential contribution of variation in native collateral 
extent and the amount of collateral remodeling was not examined in these studies.   
Thus, the physiological basis underlying genetically specified variation in ischemic injury 
has not been studied.  The purpose of this dissertation is to identify genetic sources of 
variation in extent of the native collateral circulation and its remodeling in ischemic 
disease.      
 
 
A. Collateral circulation 
 Collaterals are arteriole-to-arteriole anastomoses that occasionally are present to 
cross-connect the outermost branches of neighboring or opposing artery trees.  In 
healthy tissues, they are limited in number, have lumen diameters of 10-40 microns, and 
have virtually the same arterial blood pressure at both ends, and hence have very low 
flow with no net direction1.  Although tiny in size, collaterals offer significant protection 
against occlusive vascular diseases when abundant19, 20.  These vessels that make up 
collateral circulation in tissues are highly unique, as unique as vessels of the general 
and lymphatic circulations are from each other1.  Collaterals have at least 6 unique 
features:  1) During embryonic development, they somehow defy the canonical guidance 
molecules that ensure, in the general circulation, that arterioles always connect to 
capillaries that in turn connect to venules21.  2) They are rare in tissues – at least 500-
fold less numerous than similarly sized arterioles in the general circulation.  For 
example, the thigh of the mouse is estimated to have 10-20 of these vessels, while there 
are thousands of similarly sized arterioles in the general circulation of the thigh1.  3) 
Owing to the absence of a blood pressure drop between the two arteriolar connections 
of collaterals in healthy tissues, their flow is normally oscillatory and with little or no net 
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direction.  Yet they persist in this abnormal hemodynamic environment that, if presents 
in arteries leads to inflammation and thrombosis, and if present in the vessels of the 
microcirculation leads to their pruning away.  4) Flow is induced in collaterals when the 
trunk of one of the trees that they cross-connect becomes occluded, causing a drop in 
blood pressure at that end of the collaterals.  5) This flow causes flow mediated 
remodeling, in which collateral vessels undergo rapid and remarkable anatomic 
enlargement of their diameter (up to 10-fold), as well as longitudinal growth over a period 
of days to weeks leading to tortuosity (the process of diameter enlargement is called 
arteriogenesis).  Thus, native collaterals serve as “endogenous bypass vessels”, 
wherein their number and diameter in healthy tissues determines the level of perfusion 
and tissue injury immediately after occlusion, and the amount of recovery of perfusion 
back towards normal as the collaterals remodel1.   
Finally, 6) There is a sixth unique feature of the collateral circulation that our 
laboratory has discovered.  The density and diameter of native collaterals in tissues of 
healthy mouse strains vary dramatically as a function of genetic background, while the 
general and lymphatic circulations in the same strains are comparable in both form and 
function1, 12.  Despite the uniqueness and importance of the collateral circulation, nothing 
was known—until the work appearing from our lab in the last several--about when or 
how collaterals form (ie, signaling molecules and cellular processes) or about the 
mechanisms responsible for the wide variation in extent of the collateral circulation.   
In common with variation in anatomic and physiologic mechanisms among 
individuals, as well as in the severity of complex diseases such as diabetes, 
hypertension and cancer, variation in the extent of the native collateral circulation in 
healthy tissues and its ability to remodel in occlusive disease can be considered a 
complex trait.  The etiologyies of complex traits are, by definition, multifactorial, with 
inputs from genetic predisposition, environment and interactions between the two.  The 
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goal of this dissertation is to dissect the genetic components underlying variation in 
extent and remodeling of collateral circulation, using unbiased statistical genetic 
approaches, and thus pinpoint possible candidate genes and genetic loci governing this 
variation.  
 
    
B. Native collateral extent widely varies among individuals    
In a classic paper published in 1912, Herrick first noted that intercoronary 
anastomoses exist in man and other mammalian species, and that their number varies 
among species22.  Schaper and Maxwell systematically examined the functional 
significance of the variation in these anastomoses by comparing infarct sizes and 
collateral-dependent flow in a wide variety of species using standardized conditions and 
a single, established techniques20, 23.  Pig, rabbit, baboon, sheep, pony and wild boar 
experienced large transmural infarctions after coronary ligation owing to low collateral 
flow, while cat and dog experienced a slower progression of ischemic injury and had 
greater collateral flow.  Guinea pig, which has abundant coronary collaterals and almost 
no reduction in blood flow of the tissue area served by the left circumflex artery (LCx) 
after left anterior descending artery (LAD) ligation, sustained little or no infarction1, 20.  
These studies clearly demonstrated widespread variation in collateral extent among 
species with important functional consequences.   
Variation among individuals within a species is also present.  In an important 
paper, Seiler and his colleagues recruited 106 patients without coronary artery or heart 
disease24.  Using a 1-minute angioplasty balloon occlusion in the root of left circumflex 
artery tree, they measured a pressure-derived coronary collateral follow index (CFIp), an 
index reflecting collateral conductance.  Strikingly, an over 10-fold variation in CFIp was 
found in this cohort.  Although CFIp may be affected by other factors25, the magnitude of 
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this variation is remarkable.  Because the occlusions in this healthy population were 
acute, the variation in CFIp, in large part, reflected variation in extent of native coronary 
collateral circulation among individuals.  This variation presumably reflects differences in 
genetic and environmental factors.  These same investigators followed 739 patients with 
chronic stable coronary artery disease over a 10-year interval24.  Those individuals with 
a good collateral flow index (CFIp >= 0.25) had 75% lower mortality compared to those 
with a poor index (CFIp <0.25)24, 26.  Since these patients have coronary atherosclerosis, 
variation in CFIp involves variation in both native collateral extent and amount of 
remodeling of the collaterals that occurred as the occlusive disease progressed.  These 
results demonstrate that a wide range of variation in the coronary collateral circulation 
exists in healthy human subjects and this variation influences differential outcomes when 
the subjects experience coronary obstructive disease24, 26.    
Additional evidence for collateral variation has been found in patients with acute 
ischemic stroke cause by thromboembolic occlusion of the middle cerebral artery (MCA).  
Residual blood flow to the brain area served by the MCA in these patients was evaluated 
by various techniques: diffusion MRI, dynamic angiography or computed tomographic 
angiography27-30.  The data suggested that collateral flow can minimize the degree of 
hypo-perfusion; those patients with indices of good collateral conductance showed larger 
areas of only mild hypo-perfusion and smaller infarct size than the patients with evidence 
of poor collateral conductance.  Therefore, they concluded that collateral flow is an 
important determinant of severity of stroke27, 28.  The variation in collateral flow cannot be 
explained by differences in capacity for remodeling in these studies, because of the 
acute nature of thromboembolic stroke and subsequent neural tissue injury.  Hence, this 
variation is presumably due largely to the anatomic variation in native (pre-existing) 
collateral extent, although other factors such as individual variation in downstream 
stagnant thrombosis, thrombolysis or arterial pressure may also have contributed.   
 7 
 
Further evidence for variation in the extent of the native collateral circulation in healthy 
tissues come from the observation that residual flow to the extremities varied widely 
among young healthy soldiers who sustained acute traumatic interruption of a major 
artery31.      
 
      
C. Genetic predisposition to variation in collateral abundance  
 Variation in collateral extent among or within a species can be attributed to 
genetic factors, environmental factors, or combination of the two.  Since most species 
examined are either from outbred populations, such as humans, or domesticated 
species such as dog, it is difficult to eliminate the confounding variation in environment.  
Among inbred mouse strains, whose environment can be uniformly controlled, the 
BALB/c strain was reported to be more susceptible to 24-h focal cerebral ischemia after 
the middle cerebral artery occlusion (MCAO), compared with C57BL/618, 32, 33.  These 
differences in ischemic injury suggested that variation in collateral extent may exist 
among inbred strains and play an important role in determining ischemic injury.  
However, strength of this conclusion was diminished by the possibility that genetic 
variation in other factors which influence the response to ischemia such as inflammation, 
thrombosis and thrombolysis among strains may confound the interpretation16. 
More recent evidence has confirmed and amplified the idea that some mouse 
strains are genetically predisposed to high collateral abundance and others to low 
abundance.  Chalothorn et al. cleared, maximally dilated, and filled the cerebral arterial 
circulation which resides in the pial membrane overlying cerebral cortex in BALB/c and 
C57BL/6 mice with a fluorescent vascular casting agent.  Viscosity was adjusted to 
restrict filling to pre-capillary vessels.  Collaterals connecting the anterior cerebral (ACA) 
and middle cerebral (MCA) artery trees in both hemispheres were then counted and 
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measured for diameter16 under a microscope.  These investigators also examined 
collateral abundance in the hind limb, level of hindlimb ischemia, and the time course 
and extent of recovery after femoral artery ligation (FAL).  Their results were the first to 
show a pronounced difference in native collateral extent in the pial circulation, hind limb 
skeletal muscle, and intestine in these strains16, 34.  Subsequently, Keum et al. 
permanently occluded the distal middle cerebral artery (MCAO), thereby inducing focal 
cerebral ischemia, in the above-studied C57BL/6 and BALB/c strains plus 13 other 
inbred strains.  Infarct volume was measured 24 hours after MCAO.  Their results 
confirmed the much larger infarction in BALB/c (Bc) than C57BL/6 (B6) mice, and further 
demonstrated that ischemic injury in a surgery-induced, acute focal ischemic mouse 
model is highly variable among all 15 strains.  They created two F2 populations from two 
crosses with wide differences in infarct volume: B6 X Bc and B6 X SWR, and performed 
genome-wide linkage analyses in both populations.  They found that the extent of 
ischemic tissue damaged 24 hours after MCAO was mapped to three loci with a 
predominant locus on Chr 718.  Building on previous reports from our lab, the authors 
postulated that infarct volume assessed 24 hours after MCAO, when only minimal 
remodeling of pial collaterals could have occurred, depended to a large degree on a 
genetic difference in native collateral extent governed by these loci1.  However, collateral 
extent was not evaluated in their study.  Hence, the physiological mechanism for 
variation in infarct volume remains unclear.     
Our lab (Zhang and co-workers) subsequently quantified native collateral extent 
in the pial circulation in the same 15 inbred mouse strains.  Remarkably, a 56-fold 
variation in native collateral number and 3-fold variation in native collateral diameter 
were found among the strains.  For example, whereas B6 had on average, 9.2 
collaterals / hemisphere, Bc had almost none (~0.2).   With B6 and A/J as two extremes 
in native diameter (B6, 23um; A/J, 11um), the variation pattern for diameter across the 
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15 strains was found to not be congruent with variation in number.  Zhang et al. further 
discovered that collateral number and diameter were highly correlated with the infarct 
volume measured 24 hours after MCAO by Keum and Marchuk12, 18.  In fact, after 
measuring differences in collateral length as well as blood viscosity (hematocrit) and 
MCA tree size, these investigators were able to predict infarct volume for the 15 strains 
that closely followed the actual measured infarct volume.  These data clearly support the 
concept that genetic components underlying variation in native collateral extent are 
dominant factors responsible for variation in ischemic tissue injury.  Furthermore, 
according to their results, B6 and Bc are two extreme strains when both native collateral 
number and diameter are considered.  Thus, these strains are optimal candidate strains 
to cross for subsequent linkage analysis aimed at dissecting the genetic components 
underlying this wide variation35. 
   
 
D. Collateral remodeling 
 Arteriogenesis refers to the vascular growth (remodeling) in which collaterals 
connecting two adjacent arterial trees increase their diameter and length when the 
supply to one arterial tree is reduced or abolished8.  As mentioned above, arteriogenesis 
has long been the focus of much research, given its potential to increase collateral flow 
with time after occlusion.  In occlusive diseases such as atherosclerosis, which 
progressively narrow an artery’s lumen, collaterals can significantly enlarge 2–to–10 fold 
during disease progression, thus functioning to “bypass” the occluded vessel4, 6.  The 
capacity for vascular enlargement is known to be affected by many factors: the 
mechanical forces of as shear stress and circumferential wall stress; cellular mediators 
such as endothelial cells, monocytes and smooth muscle cells; and several important 
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molecules such as monocyte chemotactic protein-1 (MCP-1), vascular endothelial 
growth factor (VEGF), and endothelial nitric oxide synthase (eNOS)5, 7, 8, 10.  These 
studies show that many gene products contribute to arteriogenesis.  Studies from our lab 
have shown that natural genetic variation, presumably affecting these or other factors, 
contributes to wide differences in collateral remodeling among inbred mouse strains16, 36.  
However, no study has used unbiased genome-wide mapping approaches to detect 
genetic loci responsible for genetic variation in the process of arteriogenesis.  Those 
studies that did seek genetic explanations were from our lab used gene deletion 
approaches34, 37 .  Thus, key questions remain regarding regulation of arteriogenesis: 
Which genetic component(s) is(are) the most important in regulating arteriogenesis and 
variation in it?  Are the genetic components underlying variation in native collateral 
extent reflecting variation in perinatal formation of these vessels38 the same as those 
underlying variation in arteriogenesis? 
 Dokun et al preformed a genome-wide scan in B6 X BALB/c F2s using a 
qualitative necrosis score and Doppler-measured recovery of perfusion assessed 21 
days after femoral artery ligation ( a model of peripheral artery disease, PAD, in humans) 
as their traits.   They identified a major QTL chromosome 7 for both traits (LOD 8, 
necrosis score; LOD 3.7, recovery of perfusion)17. These results demonstrated that a 
genetic locus links to variation in ischemic injury and recovery of perfusion after femoral 
artery ligation.  As in the case of the pial circulation, multiple mechanisms such as 
downstream stagnant thrombosis, thrombolysis, arterial pressure and metabolic 
sensitivity to hypoxia besides variation in the collateral circulation, could affect the traits 
measured.  However, our work has demonstrated that the extent and severity of 
ischemic injury, plus the amount of recovery of perfusion, in a large part depend on 
collateral extent and collateral remodeling1, 36.  The recent findings by Zhang et al. shed 
further light on this problem:  They found that both native (initial) number and diameter of 
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collaterals, plus the amount of remodeling (fold change in collateral diameter 6 days 
after MCAO) vary substantially among 15 strains and that the rank order of remodeling 
for 15 strains is very different with that of collateral number and diameter 12.  These 
findings suggest that genetic loci that underlie variation in collateral number, diameter 
and variation in remodeling are different. 
  
 
E. Genes involved in formation of collaterals    
 Given the protective mechanism provided by the collateral circulation, important 
questions are that when and how the collateral circulation forms.  Work from our lab has 
define the when – ie, formation occurs late during embryogenesis, well after the general 
and lymphatic circulations have formed; and stabilization of the newly formed vessels 
occurs early postnatally38.  How, mechanistically, these unique vessels form is only just 
beginning to be defined.  Our group has found that differences in expression of two 
genes – Vegfa and Clic4 are involved34, 37.  And ongoing work is pursuing this in depth39.  
A goal of this dissertation is to not only identify genetic loci that determine differences in 
extent of the native collateral circulation in an individual, but by narrowing down the 
potential candidate genes in such regions, provide clues into the genes responsible for 
controlling formation and stabilization of these vessels.  Without such fundamental 
knowledge, the molecular mechanism by which collateral formation is regulated cannot 
be revealed.   
 When and how do native collaterals form and develop to their mature density and 
diameter?  Is it in the embryo, the neonate or adult?  The best tissue to examine this 
question is the cerebral circulation, because the arterial circulation is uniquely located on 
the “outside” of the cortex where it can be clearly imaged in 2D after removal of the 
calvarium.  Earlier studies showed that anastomoses cross-connecting the middle 
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cerebral artery tree (MCA) or posterior cerebral artery tree (PCA) with anterior cerebral 
artery (ACA) in the cerebral circulation, are present in new born mice and rat40, 41.  Such 
collaterals have also been found in this and most other tissue types of other mammalian 
species20, 23.  Clayton and coworkers demonstrated the presence of cerebral collaterals 
at day one post natal (P1) in mice.  They measured pial collateral number in various 
genetically engineered mice: mice overexpressing (Vegfahi/+), underexpressing 
(Vegfalow/+), mice haploinsufficient for VEGF-R1 (Vegfr1+/-; Flt1) or for VEGF-R2 (Vegf2+/-
; Flk1), and the respective wild type littermates at P1, P21, and adult (3 months).  They 
discovered that the expression of VEGF-A has a dose-dependent effect on native 
collateral density at P1.  Measurements of ischemic injury after femoral artery ligation 
indicated a similar gene dose-dependent effect among strains34.  Moreover, higher 
expression of VEGF correlated with diminished neonatal pruning over the first 3 weeks 
after birth (maturation phase).    These findings clearly suggested that native collaterals 
form during embryogenesis and are then subject to a pruning process in which mice 
experience a decline in collateral density until 3 weeks after birth. 
 When do native collaterals start to form during embryogenesis?  And what 
molecules are responsible for this early collaterogenesis?  Chalothorn et al. first 
characterized that wide differences in collateral density and ischemia-induced injury 
exists between two inbred strains: C57BL/6J and BALB/c16.  After staining the embryonic 
cerebral circulation in both strains, they found that the initial collateral anastomoses, or 
"proto-collaterals", start to form by sprouting from existing arterioles within the crows of 
opposing cerebral artery trees by E14.5 to E15.5 at points where penetrating arterioles 
descend from the pia into cortex.  Others in the lab have shown that this proto-collateral 
plexus cross-connects the opposing artery trees by taking a course of formation above 
the plane in which the cerebral capillary plexus forms39.  Then, the number of proto-
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collaterals keeps increasing through expansion of the proto-collateral plexus until 
~E18.5, followed by partial pruning through P2138.         
 The BALB/c mouse strain forms much fewer collaterals with smaller diameter, 
than the C57BL/6J mouse by E18.5;  And by P21 when the adult density and diameter of 
the collaterals has been established, BALB/c have 60% fewer and 50% smaller diameter 
collaterals than the C57BL/6J strain16.  What mechanisms account for the wide 
difference in collateral extent between two strains?  Chalothorn et al. quantified the area 
of the primary embryonic capillary present at ~ E9.0 and E12.5 in the region where the 
collaterals will form.  They eliminated the possibility that fewer endothelial cells in 
BALB/c than that in B6 are responsible.  Nor could they attribute it to differences in brain 
size or branching morphogenesis of the cerebral artery trees38.  However, collaterals in 
BALB/c were found to undergo more pruning compared with those in C57BL/6, starting 
at E18.5 to three weeks after birth.  Collateral diameter in BALB/c mice was also found 
to be smaller during embryonic formation and to increase less during the maturation 
process occurring from E18.5 to P21.  Furthermore, they reported that pericytes 
attached to nascent collaterals, which are important in stabilizing newly formed vessels, 
were comparable in both strains in all developmental stages examined38. 
 If the above mechanisms are not responsible for fewer collaterals in BALB/c, can 
genes be identified that regulate collateral formation?  Expression quantitative trait 
mapping (eQTL) in a cohort of recombination inbred lines (RILs) derived from C57BL/6 
and BALB/c parentals suggested that variation at or near the Vegfa locus associates 
with low expression of VEGF-A and PDGF-B but high expression of angiopoietin-2 in 
BALB/c42.  This pattern is consistent with less formation and maturation of collaterals in 
BALB/c.  In a report prior to the above study, Clayton et al. used x-ray arteriography in 
the middle adductor collateral zone to count collaterals in VEGF under- and over-
expressing strains and wild type34.   A positive gene-dose dependent relationship 
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between VEGF-A and collateral density in skeleton muscle was evident, along with a 
similar relationship identified in the cerebral cortical circulation as described above34.  An 
independent study in which investigators made a transgenic mouse with over-expressed 
human VEGF165 driven from a transgene in neural cells, supported this concept that 
VEGF from non-vascular cell types promotes collateral formation.  Vogel et al. found that 
the transgenic mice have 2-3 fold greater vascular density than wild type.  However, the 
cerebral blood flow was only minimally increased.  They hypothesized that additional 
vessels were inserted into the existing vascular network, and postulated that they were 
arranged as collaterals, since collaterals have no net flow in the normal healthy tissue, 
thus have no effect on normal flow irrespective of their number or diameter43.  Although 
the three-dimension imaging did not support these anatomical changes, this is likely 
because the investigators failed to examine the surface pial circulation where collaterals 
vessels reside.  A subsequent study finding smaller infarct volume and neurological 
deficits in these transgenic mice than that in wild type after MCAO is consistent with this 
expectation: more collaterals lead to smaller ischemic injury44.  On the other hand, 
several lines of evidence imply that CLIC4 also plays an important role in angiogenesis 
in general circulation: Ulmasov et al. have reported that Clic4-/- mice form fewer vessels 
normally and have impaired hypoxia-induced neo-angiogenesis in retina45, and that 
endothelial cells from Clic4-/- mice cannot form mature vessels due to failure to 
lumenized the intial endothelial cell cords (ie, failure in tubulogenesis) in vitro.  
Subsequently, Chalothorn et al. found that Clic4 disruption leads to greater reduction of 
hindlimb perfusion immediately after femoral artery ligation, worse ischemia, use 
impairment, and muscle atrophy over time.  Arteriography found 70% and 40% fewer 
collaterals formed in the pial circulation and hindlimb of Clic4 null mice by P1 and that a 
similar reduction was seen in the pia and hindlimb in adults37.      
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 In summary, these studies suggest that CLIC4, VEGF-A, and possible VEGFR1 
are important signaling molecules in the formation and maturation of the proto-collateral 
plexus in the embryonic and neonate periods1. 
 
 
F. Quantitative trait locus analysis and its statistical algorithms 
 Quantitative trait locus (QTL) analysis, also termed linkage analysis, utilizes the 
correlation between phenotypes of interests and genotypes of genome-wide genetic 
markers in a population to infer sites of genetic variation associated with variation in a 
particular phenotype.  QTL analysis provides unbiased inference about the genetic 
architecture underlying a complex trait46.  This dissertation research will utilize this 
unbiased approach to dissect the genetic components underlying variation in extent of 
native collateral circulation and collateral remodeling in mice.  In this section, we will 
discuss methodologies plus concepts of thresholds and confidence intervals (CI) used in 
a QTL analysis. 
 In the past two decades, a variety of statistical approaches have been developed 
to identify QTL in experimental organisms.  These approaches were designed to meet 
different study purposes.  Some were developed to improve statistical power and others 
to analyze for different types of distributions of traits47, 48.  These approaches are 
classified into specific categories: single-marker analysis or interval mapping according 
the locations of the statistical tests performed; single QTL model vs multiple QTL model 
mapping according to statistical modeling; likelihood based or Bayesian based 
approaches46, 49, 50.   
 Single-marker analysis does not require estimating the genetic distance between 
markers and is simple to conduct.  And it conveys the key idea of linkage analysis:  the 
phenotypic difference at one QTL is linked to genetic markers51.  Accordingly, a simple t-
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test can be performed to detect the marker close to a QTL, or ANOVA can be used in 
the case of an F2 population52.  Though simple, single-marker analysis cannot estimate 
the QTL position.  Moreover, estimation of the QTL effect can be confounded by the 
genetic distance between the QTL and the markers46.    
 To overcome these limitations, Lander and Botstein proposed an interval 
mapping in which a statistical test can be conducted at any location between two 
adjacent markers53.  With the assumption that a QTL has a linear effect on the 
phenotype of interest and that the phenotypes of each genotyped group of individuals 
follow a normal distribution, the problem of detecting a QTL becomes one of testings 
whether the coefficient for the QTL equals zero.  Treating unobserved genotypes at a 
QTL as missing data, these investigators used the maximum likelihood-based 
approach—an expectation-maximization (EM) algorithm54—to detect the genetic effect 
and position of a QTL.  To improve computational efficiency, Haley and Knott, in addition 
to several other researchers55-57, proposed a linear regression-based interval mapping 
method, in contrast to maximum likelihood (ML)-based interval mapping.  Similarly, they 
also assumed a linear relationship between the QTL and phenotype and a normal 
distribution.  However, Haley and Knott replaced the unobserved genotypes for the QTL 
with the expectation of a genotype conditional on the two flanking markers.  Using a 
linear regression framework, this mapping process is much faster, and additional 
covariates are easily handled.  In addition, almost any standard statistical software can 
be programmed to run the analyses55. 
  Single QTL mapping algorithms that detect QTL one-at-a-time are robust but not 
ideal for most complex traits, since such traits are usually affected by multiple loci each 
with small effects.  This problem becomes evident when two closely linked QTL reside 
on the same chromosome, often resulting in a "ghost" peak58. To remove the 
confounding effects from the nearby QTL, Zeng et al. developed composite interval 
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mapping (CIM) in which they introduced additional markers as covariates.  Since 
choosing appropriate markers as covariates is an important issue in this algorithm, Zeng 
provided detailed guidelines59.  Although CIM can simultaneously account for multiple 
QTL effects, it is not capable of detecting interactions between loci, which are very 
common in most complex traits46.  Further, the mapping result from CIM is sensitive to 
the additional markers that are chosen59. 
 Simultaneously searching for multiple loci in the whole genome can be viewed as 
a model-selection problem in which the genotypes at any location in the genome can be 
potential covariates.  The challenge of the mapping process is to identify the best 
covariate set or interactions between these covariates60.   Kao et al. extended the 
likelihood-based interval mapping methods originally developed by Lander and 
Botstein61.  They derived variance-covariance matrices for both positions and genetic 
effects of k putative QTL, in addition to accommodating for interactions.  Haley and Knott 
proposed a model-selection strategy based on linear regression55, while Churchill et al. 
developed a selection method based on Monte Carlo Markov Chain (MCMC) imputation 
for multiple QTL allowing interaction62.  All these algorithms involved a model-fitting 
process and a model-selection criterion.  While most criteria for selecting a model, such 
as Akaike information criterion (AIC) or Bayesian information criterion (BIC), are 
especially liberal in terms of interactions, Speed and Broman improved a penalized 
likelihood method as a model-selection criterion63.  They considered strictly additive QTL 
models and generated the null distribution of genome-wide maximum LOD score by 
permutation to derive the penalty.  By penalizing the LOD score, they apply an empirical 
control over rate of inclusion of extraneous loci, instead of classifying a prior distribution 
in Bayesian criterion63.  Manichaikul and Broman extended this idea and included pair-
wise interaction in the model64.  In this algorithm, the LOD score is first penalized by 
main effects.  The resultant score is further penalized by the interactions among QTL, 
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which are obtained by permutations to control false-positive rate.  The LOD scores 
penalized by both interactions and main effects are then used as criteria to choose the 
best model.  In summary, the above approach provides a straightforward and versatile 
QTL model selection.  It directly controls the false-positive rates and avoids the 
uncertainty of choosing a prior46, 64.  In addition to likelihood-based and regression-based 
algorithms, Bayesian approaches are also being rapidly developed for multiple QTL 
mapping65-69. 
 Churchill et al. developed a permutation test of estimating empirical threshold for 
declaring a significant QTL.  By shuffling subject numbers and disrupting the association 
between the phenotype and the genetic markers in an individual, permutations derive a 
null distribution of maximum LOD scores.  Empirical thresholds derived by permutations 
have proved to be robust and widely accepted by the field46, 70.  Constructing a 
confidence interval (CI) for a QTL, on the other hand, is challenging with the need to 
uncover the underlying genes for complex traits.  A QTL region resulting from a classical 
F2 intercross typically contains hundreds of genes.  To further narrow this region down, 
several algorithms have been proposed to accurately locate a 95% CI.  The LOD drop-
off method of Lander and Botstein is widely used to construct a CI because of the 
simplicity.  An approximate 95% CI in a backcross or an F2 population equals a 1.5 -1.8 
LOD drop on both sides of the peak53.  Some researchers argue that the drop-off 
method is very biased when the QTL has a small effect.  Mangin et al. proposed a 
likelihood ratio test framework for locating the 95% CI.  Their simulation demonstrated 
that the 95% CI obtained by their algorithm has a higher probability to contain the true 
map location71.  Visscher and Haley developed an empirical CI algorithm using 
bootstrapping.  Simulations showed that calculating CI using bootstrapping performed 
very well regardless of the population size or effect.  However, estimating CIs using this 
approach is slightly biased towards the conservative when segregation of alleles is 
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scarce or correlations between adjacent markers are strong46.  Recently, Manichaikul et 
al. recommended a Bayesian method to calculate the 95% CI, and their simulation 
results suggested that the Bayes credible interval performed very well regardless of the 
effect size of the QTL, marker density, and sample size72.   
 In summary, multiple QTL model mapping takes into account the effects from 
other loci and, and thus increases statistical power46, 49.  Although more complicated and 
computationally intensive, it is a superior approach for mapping of QTL for complex 
traits.  The Bayes credible interval derived by Manichaikul et al. for defining the 95% CI 
is more accurate regardless of conventional confounding factors72.  
    
 
G. Association mapping in mice and its statistical algorithms 
 A key goal of this dissertation is to identify novel gene candidates governing 
native collateral extent.  To this end, association mapping in mice is a powerful tool.  In 
association mapping, one uses a large number of genetic markers and inbred mouse 
strains to test for association between a trait and a genotype, treating each strain as an 
individual from a population73.  Bi-allelic SNP status at a single locus across a panel of 
inbred strains, in most cases, is insufficient to discern the complex genomic structure.  
Instead, allele patterns across multiple loci (i.e., haplotypes) are more appropriate to 
represent the inheritance structure74.  These observations have led investigators to 
define multiple adjacent SNPs over a local window as haplotype.  Inferred haplotype is 
then used as a classification variable for haplotype association mapping (HAM) across 
the genome74, 75.    
 Grupe et al. first applied association mapping in mice.  They used approximately 
3,350 SNPs in 8 inbred strains and found that a proportion of predicted QTL for 10 
phenotypes overlapped with previously verified QTL for narrower regions76.  This 
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approach initially drew significant criticisms, e.g., for high false-positive rate, limited 
sample size, and uncertainties about the population structure embedded among the 
inbred strains77.  As such, association mapping methodologies are currently under 
considerable improvement to address these limitations.  The simplest association 
mapping algorithm is to perform a t-test at every bi-allelic locus along the genome.  This 
approach has been successfully applied to identify sweet preference loci74.  However, 
because of small sample size and frequent switching of group classification along the 
genome, it is not possible for this approach to meet the t-test assumptions of normality 
and homogeneity of variance.  Furthermore, this parametric approach not only cannot 
meet these assumptions, but it also suffers from the fact that the bi-allelic status of 
alleles cannot account for the complexity of underlying genetic variations among inbred 
strains73, 74.  To address this limitation, a haplotype consisting of a three-SNP sliding 
window is used as the classification variable, and an F-test is constructed to measure 
the association74.  However, this approach still requires normality assumption.  A rank-
based non-parametric test was therefore introduced.  In this approach, a Kruskal-Wallis 
test statistic is constructed along the genome.  The Kruskal-Wallis test statistic, which is 
based on rank information, discards quantitative information contained in the original 
dataset and, thus, lowers statistical power to detect association.  To alleviate this 
problem, a bootstrap-based F-test was conducted at every three-SNP window.  Instead 
of parametric Fisher distribution, the distribution of the test statistic is empirically 
estimated by drawing a bootstrap sample74.  However, population structure and 
relatedness among inbred strains due to the genealogical history can cause spurious 
associations and high false-positive rates.  Yu et al. suggested that a mixed linear model 
can correct this problem by modeling relatedness as random effect78.  Recently, Kang et 
al. developed an efficient mixed model for association mapping (EMMA)79.  They used a 
simple genetic similarity matrix estimated by a regression approach80 to serve as the 
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kinship matrix.  By accounting for the relatedness among inbred strains with this kinship 
matrix, they estimated the random effect using the maximum-likelihood approach instead 
of using an iterative algorithm.  This method is much faster than other commonly used 
implementations by orders of magnitude79.  Moreover, applications of EMMA to previous 
datasets gave almost identical results as those derived from earlier algorithms73, 78, 79, 81.   
 Although initially limited by the few strains available, population structure, and 
inappropriate statistical algorithms77, hundreds of studies employing association 
mapping have been published in the past few years with the development of new 
statistical algorithms73, 74.  For example, Liu et al. combined 173 phenotypes in the 
Mouse Phenome Database (MPD) with 148,062 SNPs in order to identify 937QTL.  They 
refined 67% of the experimentally found QTL to a genomic region of less than 0.5Mb 
with much-increased precision82.  Bennett et al. recently applied the EMMA algorithm to 
a hybrid mouse diversity panel consisting of classic inbred and recombinant inbred 
strains.  They verified this algorithm by mapping over 2500 cis-expression QTL83.  The 
EMMA algorithm can effectively correct the population structure which previously limited 
association mapping in model organisms.  Ghazalpour et al. applied this algorithm to an 
outbred mouse stock, the MF1, and successfully replicated expression QTL identified in 
previous F2 intercrossed mice84.   
 Several bioinformatic tools are available to narrow down QTL identified by 
linkage analyses: comparative genomics, combined cross analysis, and interval-specific 
haplotype analysis85, 86.   Compared to other bioinformatics tools, EMMA benefits the 
goal of narrowing the CIs through its speed, accountability of population structure, 
precision, and use of maximum information from the inbred strains examined73.  With the 
aim toward assessing the utility of association mapping in mice, a recent study 
conducted association mapping for red blood cell and high lipoprotein cholesterol.  The 
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investigators found that 78% of 54 haplotype association mapping peaks were true-
positives and 22% false-positives in significant allelic association with real QTL87. 
 Given the discussion of aforementioned algorithms for linkage analysis and 
association mapping, we will conduct linage analyses utilizing both single- and multiple-
QTL model mapping algorithms in a B6 X BALB/c F2 population.  The 95% CI will be 
extracted using Bayes creditable interval.  The 95% CI of the most significant QTL will 
then be narrowed by the EMMA mapping utilizing the collateral extent data collected 
before12.  
 
 
 
 
 
 
CHAPTER II 
 
EXPRESSION QTL MAPPING IN A DIVERGENT MOUSE CROSS  
SHOWS THAT MOST EQTL “HOT SPOTS” ARE CAUSED BY TRANSCRIPT 
CORRELATION STRUCTURE AND SIMPLISTIC STATISTICAL MODELING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This Chapter describes the project that I had done in the Dr. Daniel Pomp's laboratory   
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A. Abstract  
 Transcriptional hot spots, defined as chromosomal regions which contain more 
expression quantitative trait loci (eQTL) than expected by chance, have been detected in 
many studies. Often, hot spots have been hypothesized to harbor genetic variation (i.e. a 
master transcriptional regulator) which controls variation in mRNA abundance for 
hundreds or even thousands of genes. We tested the hypothesis that high pair-wise 
correlations among transcripts, and oversimplified statistical modeling during eQTL 
mapping, might create spurious hot spots. We evaluated multi-tissue eQTL data on ~400 
mice from a large F2 population created by crossing a polygenic obesity mouse strain 
(M16) and its non-obese control line (ICR). eQTL mapping with classical modeling was 
performed in hypothalamus, muscle, liver and adipose. Hot spots were identified based 
on harboring eQTL for >130 transcripts within a 5 cM window. We first characterized the 
gene action and allelic effects of the eQTL within hot spots to understand their overall 
genetic architecture. A permutation test, where genotypes were permuted while 
conserving gene expression phenotypes and the internal correlation structure of the data, 
was conducted to test if any of the hot spots were caused by high correlation structure 
among transcripts. Finally, we explored appropriate statistical modeling for eQTL 
analysis in the context of hot spot detection, by accounting for effects from transcription 
of genes other than the one being analyzed, and the network to which a transcript is 
belonged. 
 A total of 11 eQTL hot spots were identified, with no overlap across the four 
tissues. Underlying genetic architecture varies widely across hot spots in regard to 
additive and dominance effects and direction of allelic effects of the eQTL. Permutation 
testing revealed that only one of the 11 hot spots, with >2000 eQTL on MMU17 in 
hypothalamus, showed genome-wide significance (p < .05). In addition, by accounting 
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for highly correlated transcripts and network effects in the eQTL analysis, all eleven hot 
spots disappeared. We conclude that in this data set most hot spots are artifactual due 
to the high pair-wise correlation among transcripts and/or oversimplified statistical 
modeling. 
 
 
B. Introduction 
 To understand the transcriptional landscape underlying a complex trait, 
expression quantitative trait locus (eQTL) mapping systematically identifies genetic 
variation that controls phenotypic variation in mRNA abundance on a genome wide 
basis53, 88, 89. During eQTL mapping, a commonly observed yet striking phenomenon is 
the identification of transcriptional hot spots, also known as trans-bands90, 91. A 
transcriptional hot spot is defined as a chromosomal region which contains more eQTL 
than expected by chance92, characterized by the apparent clustering of several hundred 
and even thousands of trans-acting eQTL, within a relatively small chromosomal window. 
Given the almost ubiquitous nature of hot spots in eQTL studies, it is imperative to gain a 
better understanding of why they arise and what, if any, biological significance can be 
attributed to them.  
 There are several interpretations regarding the existence of eQTL hot spots. First, 
it has been hypothesized that a regulatory element, disrupted by one or more 
polymorphisms in a hot spot, leads to widespread changes of downstream transcript 
abundances93, 94. Transcription factors (TFs), tRNA synthetases or other important 
regulatory elements within a hot spot have been proposed to be responsible for this 
regulation. The mechanism of this type of regulation was explored by Sun et al (2007) 
using statistical methods. They identified four eQTL modules which feature a common 
sequential regulation pattern mediated by TF activity: DNA polymorphisms, cis-linked 
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genes, TF activity and downstream linked genes. In another study, Mozhui et al (2008) 
identified several candidate tRNA synthetase pertinent proteins as potential master 
regulators within a hot spot on the distal part of mouse chromosome 1. Second, one or 
more cis-acting upstream genes in an enriched pathway has been hypothesized to be an 
underlying cause of eQTL hot spots. Wu et al. (2008) performed a genome-wide 
association analyses for expression in adipose and reported over 1600 candidate hot 
spots in 28 inbred lines. They examined the hot spots for enrichments in functional gene 
sets representing known biological pathways and discovered several novel upstream 
regulators in the pathways95.  
 In contrast, it has been proposed that hot spots are artifacts or at least that they 
cannot necessarily be interpreted as master regulators. In a simulation study, Pérez-
Enciso (2004) showed how hot spots can be caused by high inter-correlation between 
transcript levels. Similarly, Breitling et al (2008) hypothesized that most hot spots are 
artificially generated due to highly correlated gene expression among transcripts or 
linkage disequilibrium among markers. They proposed permutation strategies, where 
genotypes are permuted while conserving gene expression phenotypes and the internal 
correlation structure of the data, to test the significance of hot spots. A second theory is 
that hot spots are at least partially artificially caused by oversimplified statistical 
modeling during eQTL mapping96. The rationale is that the complex regulatory elements 
for the expression level of a gene cannot be just confined to underlying genetic factors. 
Perez-Enciso et al. (2007) found that transcripts other than the one being analyzed 
explain on average much more variability than the markers themselves using support 
vector machine. 
 Given the strong interest in eQTL hot spots, how and why they arise, and what 
biological meaning they have, the objective of this study was to assess the nature of 
eQTL hot spots by employing appropriate model-free permutation testing, and more 
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complex statistical modeling, in their detection. To achieve this goal, we systematically 
identified and characterized eQTL hot spots in four tissues from a large F2 mice 
population. Surprisingly, our results demonstrated that, for this specific mouse cross, the 
vast majority of identified eQTL hot spots appear to be artifactual in nature.  
 
 
C. Materials and methods 
Mice 
 The F2 population used has been previously described96-98. Briefly, a large F2 
population (n = 1,181) was established by intercrossing the M16 and ICR long-term 
selection lines97, 99. Twelve F1 families resulted from six pair matings of M16 males × ICR 
females and six pair matings of the reciprocal cross. A total of 55 F1 dams were mated to 
11 F1 sires in sets of five F1 full sisters mated to the same F1 sire. These same specific 
matings were repeated in three consecutive replicates. All litters were standardized at 
birth to eight pups, and mice were weaned at 3 weeks of age and provided ad libitum 
access to water and pellet feed (Teklad 8604 rodent chow). Mice were caged individually 
from 4 to 8 weeks of age. All procedures and protocols were approved by The University 
of Nebraska Institutional Animal Care and Use Committee prior to experiments. 
 
RNA sample preparation and hybridization 
 As previously described98, global expression analysis was determined using the 
23,574-feature mouse Rosetta/Merck Mouse TOE 75k Array 1 (Gene Expression 
Omnibus (GEO) Platform: GPL 3562; Agilent Technology, Palo Alto, CA, USA). 
Transcriptonal analysis was performed in hypothalamus (n = 451 F2 mice), liver (n = 441), 
epididymal (males) or perimetrial (females) adipose (n = 477), and gastrocnemius 
muscle (n = 465). Labeled cRNA from each F2 animal was hybridized against a pool of 
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labeled cRNAs constructed from equal aliquots of RNA from 160 F2 animals for each of 
the tissues in the cross that was balanced for sex and litter100. Microarrays were scanned, 
and individual feature intensities were pre-processed by background subtraction, 
normalization to mean intensities of the Cy3 and Cy5 channels, and detrending to fit a 
linear relationship between channels. Normalized intensities were used to derive 
expression ratios using the Rosetta error model98.  
 
Expression QTL mapping 
 Expression QTL (eQTL) mapping was performed using R code in the following 
steps. First, we built linear regression models with appropriate fixed effects and 
covariates, including sex, replicate, and family. This represented the null model. Second, 
at every cM position throughout the genome, the probability for parental line of origin for 
each F2 individual was estimated based on flanking marker genotypes101. Third, we 
modeled the additive and dominance effects of each locus as presented by Haley and 
Knott (1994). We then added the additive and dominance effects and their interaction 
with sex into the null model as a full model to analyze the expression phenotypic data. 
Fourth, the likelihood ratio test (LRT) score for each locus was approximately calculated 
according to the ratio of two residual of sum squares from the two models55. Similarly to 
Schadt et al (2003), we used an LRT of 20 (LOD = ~4.4) as the significance threshold for 
an eQTL102.  
 
Detection of eQTL Hot Spots 
 To evaluate the distribution of eQTL, we plotted the number of eQTL detected at 
every cM position along the genome in each tissue (data not shown). At positions where 
eQTL tended to cluster, we evaluated the distribution of eQTL within extending cM 
windows. Based on this distribution analysis (data not shown), we defined an eQTL hot 
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spot as a cluster of >130 eQTL within a 5 cM window. This threshold of eQTL for a hot 
spot to be present is conservative, being significantly greater than that used in other 
studies (e.g. Wu et al., 2008), with a goal of evaluating the veracity of only the strongest 
signals in our study. 
 
General genetic architecture of eQTL hot spots 
 Within each eQTL hot spot region, additive and dominance effects for each eQTL 
were estimated by regression.  The direction of allelic effects was obtained by the sign of 
regression coefficients of the additive or dominance effects. If an eQTL has an additive 
effect on the mRNA abundance of a transcript, the regression coefficient for this additive 
effect was extracted from the additive model. A positive sign indicated that the M16 
allele increases the expression level since we modeled the additive effect as the 
difference of line origin probabilities between both alleles from M16 and both from ICR. 
Similarly, directions of dominance effects were determined. 
 
Permutation Testing 
 We applied permutation testing to artificially disrupt the relationship between 
transcription level and genotype while maintaining the correlation structure between 
transcripts. This was achieved by permuting mouse ID for expression phenotypes but 
maintaining the actual expression data within each mouse. We then performed eQTL 
mapping and hot spot detection as described above in each of 1000 permuted data sets. 
The strongest hot spot (with the most eQTL) was recorded in each permutation and 
ranked within each tissue separately. The genome wide p value for significance of the 
presence of a hot spot was defined as the probability of the number of eQTL clustered 
under the null hypothesis being equal to or greater than the observed number clustered. 
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Gene covariates selection to remove hot spot effects in eQTL mapping  
 To test whether eQTL hot spots may arise because an effect common to several 
variables is not accounted for properly in the statistical modelling, we further investigated 
the covariate modelling proposed in Pérez-Enciso et al (2007). We postulated that 
modelling strongly influences the eQTL P-value profiles and that expression data for a 
given gene could be modelled using, potentially, the rest of the gene expression levels. 
We utilized an efficient and robust modelling strategy based on forward selection and 
bootstrap model aggregation, bagging103, in order to model directly these hidden effects 
prior to eQTL mapping of the expression trait. Given a gene A, the effect of all other 
gene expressions can be estimated from: 
 ,        
 (1) 
where yiA is the expression measure for gene A and i-th individual, µA is a global mean, 
βmA is the effect of a putative covariate m on the expression level of the gene A, e is the 
residual. Therefore, the set of covariates m measures the influence of external gene 
expression levels (yim) on the expression of the gene studied (A). Deciding about the 
optimum model in this situation poses an enormous challenge computationally because 
of the almost infinite number of potential models. Here we used a forward selection 
approach combined with a bootstrap procedure in order to incorporate model 
uncertainties. At each stage, the most significant gene expression level j was included 
as a new covariate in the modelling of the expression levels of the gene A and the 
effects of the remaining candidates were re-evaluated one at the time successively given 
the new model 
,       
 (2) 
iAm immAAiA
eyy ++= ∑ βµ
iAijjAm immAAiA
eyyy +++= ∑ ββµ
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where m indexes the covariate genes already included in the model and j, the remaining 
covariates to test. The addition of covariates in the model was stopped when no 
candidates reached the significance threshold of P = 10−5. Fitting was done using least 
squares and the significance of the effects was obtained from an F-test.  
This variable selection was repeated on 1,000 different bootstrap samples of the data104 
to incorporate uncertainties on the model building and minimize the risks of false 
positives103. The proportion of models where the gene B was covariate of the gene A is 
the bootstrap probability (BP) of this relationship between genes A and B.  
 The final model can be depicted as a directed network where B being covariate 
to A can be represented as directed edge between genes A and B (B → A) when the BP 
is not null. It can happen that A is selected to be covariate of B and vice versa, i.e., B is 
selected as covariate to A. In this case, we retained only the edge with largest BP.  
Remaining covariates with a BP lower than 0.25 were deemed not to be reliable and 
also suppressed from the network. Note that some edges may still remain ambiguous if 
they have equal BP in two directions B → A and A ← B.  Then the edge was removed if 
the two genes were located on the same chromosome considering that the ambiguity 
could result from genetic linkage. Nonetheless ambiguous edges were rare (0.5 to 1%). 
Next, eQTL mapping for gene A was carried out with the NET-model determined by the 
bootstrap procedure: 
        
 (3) 
where m indexes the covariates of the gene A in the network, as described above, αlA is 
the effect of the locus l on the gene A, ql is the additive QTL coefficient at the tested 
locus l. For computational simplicity, no other effects were included in the model, and 
this analysis was performed for selected hot spots (hypothalamus MMU17, and muscle 
iAillAm immAAiA
eqyy +++= ∑ αβµ
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MMU15, MMU17). QTL effects were tested against the null model of no QTL with an F-
test.  Results were reported as the –log10 of the P-value. Genome-wide maximum score 
for each gene was recorded. The location of this maximum is the most likely eQTL for 
the gene given a one QTL model, and therefore this maximum will be referred as the 
eQTL for the gene. These eQTL will be classified as cis or trans whether they were 
positioned locally (≤ 5 cM) or distant (≥ 5 cM) to the gene position, respectively. 
 
Simulated datasets 
 To further explore the behavior of the NET modelling, we simulated two 
scenarios that comprised 1000 genes and 450 F2 individuals. The first scenario (Sim1) 
consisted of a gene regulatory network, whereas in scenario 2 (Sim2), gene co-
expression was caused by a block correlation matrix among gene expressions. Genome 
simulations were based on the sex-averaged map of Shifman et al.105 for the 19 
autosomal mouse chromosomes. A position in the genome was assigned randomly to 
each gene. Marker and QTL genotypes in the F2 individuals were simulated using 
R/qtl106. Only one QTL, located in cis position, was simulated for every gene. 28 
replicates per scenario were simulated. 
In Sim1, a topological rank in the network was assigned to each gene; a gene can be 
regulated only by a gene with a higher topological rank. The expression levels of the kth 
gene for the ith individual were simulated according to 𝑦𝑖𝑘  ~ 𝑁(𝑦�𝑖𝑘 ,𝜎𝑒)  where 
𝑦�𝑖  ~ 𝑁(∑ 𝑐𝑗𝑘𝑦�𝑖𝑗 + 𝛼𝑙𝑘𝑞𝑖𝑙 ,𝑗 𝜎𝑡), where j indexes the parents of the gene k in the network, cjk 
is the regulatory effect of the parent j on the gene k, αlk is the additive effect of the cis-
QTL l of the gene k, qil is the indicator variable of the genotypes at l, σt is an error that 
will be transmitted to any genes down-regulated by the gene k, whereas 𝜎e is a non 
transmitted error. We set-up 𝜎t = 0.02 and 𝜎e = 0.98. The gene effects c were all linear 
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with absolute effects uniformly drawn from 0.1 – 0.3, with 2.5% of them negative and the 
rest, positive so the network was strongly directionally biased. Additive effects of QTL 
were always 5 % of the phenotypic variance conditional on the network component, i.e., 
𝑦�𝑖 − ∑ 𝑐𝑗𝑘𝑦�𝑖𝑗𝑗 . This results in an effect size that is negatively related to the topological 
rank and ranged between 5% and 1% of the variance in expression. Signs of the QTL 
effects (σ) were either always positive or 50% positive. 
In Sim2, the expression levels were drawn from 𝑦𝑖  ~ 𝑀𝑉𝑁(𝑎𝑞, 𝑆), where yi is the vector 
of gene expression levels of the individual i, a is the vector of additive effects.  Each cis-
locus had an effect of 5% the phenotypic variance. Two cases were considered, either 
all effects were positive or 50% of the effects were positive and 50%, negative; q is the 
indicator vector of genotypes of the individual i at the cis-QTLs. S is a ten-block 
covariance matrix with high correlation among genes within a block (r = 0.8) and null 
correlation among genes in different blocks, and diagonal values 𝜎e equals to 1. The 
number of genes in each block was 100. 
 We computed power as the proportion of significant linkage (P ≤ 10 –3) at the 
gene positions. The FDR was estimated as the proportion of significant ( ≤ 10-3) genome-
wide maximum scores that were not linked given a genetic distance between the 
transcript and the eQTL greater than 15 cM. 
 
 
D. Results  
eQTL show strong tissue-specific patterns 
 We found that 28%, 41%, 28% and 39% of transcripts have eQTL among 23574 
transcripts on the arrays in adipose, hypothalamus, liver and muscle, respectively 
(Figure 2.1). Of these eQTL, 1432 (21.47%), 1584 (23.88%), 1983 (20.08%) and 2085 
(22.72%) were classified as cis-acting in each respective tissue (Figure 2.1, Diagonal). 
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Across the tissues, 739 (5.05%) transcripts have eQTL in all four tissues, and 330 of 
these are in similar positions in every tissue (Figure 2.2). The heatmap for eQTL (Figure 
2.1) strongly suggests that eQTL distribute across the whole genome in a tissue-specific 
pattern. This tissue-specific distribution pattern is especially evident for the eQTL hot 
spots as demonstrated by the vertical lines (Figure 2.1). Strikingly, there are no 
overlapping hot spot clusters across the tissues.                
 
Characterization of eQTL hot spots within and across tissues 
 Applying our definition of an eQTL hot spot to the four tissues, we identified a 
total of 11 independent hot spots (Table 2.1). Among them, three were in adipose, three 
in hypothalamus, one in liver and four in muscle. The number of eQTL within each hot 
spot vary dramatically, with the strongest encompassing 2112 eQTL on MMU17 in 
hypothalamus and the weakest having 139 eQTL clustered on MMU19 in adipose (Table 
2.1).  
 To further understand the genetic architecture of eQTL hot spots, we tested 
whether the transcript eQTL within each hot spot have predominantly additive or 
dominance gene action. Interestingly, as shown in Table 2.1, some hot spots have eQTL 
whose effects are nearly all additive in nature (MMU17 in hypothalamus), some are 
strongly biased towards dominance gene action (MMU8 in muscle), while others have 
nearly equal representation (MMU7 in hypothalamus). Cumulatively, however, there is 
significantly more additive eQTL in hot spots than eQTL with dominance effects.  
 In addition, we characterized the direction of allelic effects for eQTL localized 
within hot spots, articulating whether an allele inherited from the M16 parental line 
increases or decreases mRNA abundance relative to an allele from the parental ICR line 
(Table 2.1). We also evaluated the direction of dominance. In general, direction of allelic 
effects was relatively evenly distributed across the two parental lines, although this was 
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hot spot specific. For example, 90% of the additive eQTL in the adipose hot spot on 
MMU9 had increased expression values due to the M16 allele, while the opposite was 
seen for the muscle hot spot on MMU15. And for the strongest hot spot in hypothalamus 
on MMU17, nearly the same number of eQTL had increased expression values due to 
the ICR and M16 lines. In regard to dominance, the most interesting finding was for the 
muscle hot spot on MMU8, where nearly all the eQTL showed directional dominance 
based on the ICR allele. 
 
Most hot spots arise due to high correlations between transcripts 
 Based on permutation testing (Figure 2.3), only one of the hot spots (MMU17 in 
hypothalamus) was significant. For the hot spot on MMU17 in hypothalamus with 2112 
eQTL, the P value was equal to 0.01 that this hot spot did not arise by chance after the 
association between marker genotype and expression was artificially broken, while 
maintaining the correlation structure between transcripts. The P values for other hot 
spots were 0.9, 0.6 and 0.25 for the strongest within-tissue hot spots on MMU7 in liver, 
MMU15 in muscle and MMU2 in adipose, respectively. These results provide model-free 
evidence that most hot spots arise because of correlation structures among transcripts.  
The average pair-wise correlation among the transcripts with eQTL in the hypothalamus 
hot spot on MMU17 was 0.64. This was significantly higher (P < 10XE-30) than the pair-
wise correlations calculated for sets of 1000 random transcripts, where the highest 
average correlation obtained was 0.45 using 10000 permutations. 
 
Evidence from network modelling 
 In order to reduce computational burden, only the set of genes that make up the 
same hot spot as that of gene A were considered as putative covariates for a gene A. As 
case studies, we analyzed three hot spots: the strongest one on MMU17 in 
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hypothalamus, and two in muscle (MMU15 and MMU17). For this specific analysis, 
these two muscles hot spots were evaluated together as a single set of genes (in 
preliminary analyses modelling was done on the two gene sets independently, but 
results were similar what is presented here because selected covariates for a gene were 
mostly from the same set of genes when the two sets are analyzed simultaneously).      
Modelling was initialized using first-order partial correlations107 with the null hypothesis of 
zero correlation rejected at P ≤ 10 –2. Sex-specific expression levels (P ≤ 10 –2) were 
identified only for a few genes in the hypothalamus hot spot (2.3%), whereas 60.5% of 
the genes in the muscle hot spots exhibited sex-specific expression (69.7 % for muscle 
MMU15 and 48.7% for muscle MMU17). A gender effect was therefore incorporated for 
these genes. 
 The NET model yielded a dramatically different picture compared to the classical 
mapping (Figure 2.4C, 2.4D versus Figure 2.4A, 2.4B): i) the large hot spots 
disappeared; ii) the cis diagonal was highlighted instead, reflecting the increase in the 
number and in the significance of cis QTL as compared to model 0; iii) few of the 
remaining trans-eQTLs showed highly significant scores. The number of eQTL was 
reduced by approximately 30% (Table 2.2). However, with stricter significance 
thresholds, the NET model detected up to 4-fold more eQTL than the traditional M0 
model in the hypothalamus gene list and in the muscle gene list (Figure 2.5A). In 
contrast, the NET model had no effect whatsoever on the muscle MMU17 gene list, as 
the ratio of detected eQTL between models M0 and NET was roughly 1. However, of the 
111 genes with eQTL at the hot spot, 42 were actually cis-eQTL in the classical mapping. 
About 16% of the genes in the MMU17 gene list are located on chromosome 17, 22 of 
the genes are physically located within a 2 Mb region of the eQTL hot spot, and 18 
additional genes are within 15 Mb of this region.  
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Overall, the number of cis-eQTL dramatically increased (2 to 4-fold) with the NET model 
in the hypothalamus and muscle MMU15 hot spots, whereas no gain was observed on 
the muscle MMU17 gene list (Figure 2.5B). In the hypothalamus, this gain was from 128 
to 336 in significant cis-eQTL, representing an increase from 7.2% to 29.2% out of the 
total number of significant eQTL (Table 2.2). This increase was consistent whatever the 
distance used to decide whether the eQTL was proximal or distal to the gene (Figure 
2.6). Similarly, a two-fold increase was observed in the muscle hot spot on MMU15. The 
number of cis-QTL increased from 21 to 51 (6.5 to 19.7%) in the MMU15 gene list, 
whereas there was no increase in cis-QTL for genes in muscle hot spot on MMU17 in 
model M0 vs. NET model (72 vs. 68 cis-eQTL, or 32.7 vs. 32.8% of the total number of 
significant eQTL).  
 
Evidence from simulations with high correlations between transcripts  
Gene network 
 Simulations of expression levels of 1000 genes controlled by one cis-eQTL per 
gene and a complex gene network yielded a clearly visible pattern of eQTL clustering 
when a naïve QTL model is employed (Figure 2.7A). Moreover, the NET model 
consistently removed this hot spot pattern while highlighting the cis-signals (Figure 2.7C). 
The NET approach did not increase the power of the analysis as the power changed 
from 0.59 ± 0.16 to 0.58 ± 0.16 when the QTL effects were either positives or negatives, 
and from 0.79 ± 0.16 to 0.65 ± 0.16 when these effects were all positives. The rate of 
false discovery was, however, consistently reduced from 27.1% ± 1.8 to 24.3% ± 0.99, 
positive and negative QTL effects, and from 31.3% ± 2.2 to 24.1% ± 1.2 when all QTL 
effects were positive.  
Block correlation matrix among gene expressions 
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 The second type of simulations was based on a block-correlation matrix among 
gene expressions of 1000 genes (100 genes in each of ten blocks). As in the previous 
simulation scenario, the traditional mapping resulted in eQTL hot spots whereas the NET 
approach removed the hot spot structure (Figure 2.7B and 2.7D). Nonetheless, these hot 
spots were less frequent than when a network was simulated. Modelling did not affect 
power: it varied from 0.57 ± 0.27 to 0.61 ± 0.24 when the QTL effects were either a 
mixture of positives and negatives, and from 0.64 ± 0.29 to 0.59 ± 0.23 when they were 
all positives. The rate of false discovery was only marginally reduced with the NET 
model when the QTL effects were either positives or negatives, 13.7 % ± 1.4 vs. 11.1 % 
± 0.9 with M0 and NET modelling, respectively. No improvement in FDR was observed 
when all QTL effects were positive (M0: 13.4 % ± 1.6 and NET: 13.7 % ± 1.4).  
 
 
E. DISCUSSION 
 Clusters of colocalized trans-eQTL, otherwise known as trans-bands or 
transcriptional hot spots, have been identified in many studies in variety of organisms, 
including yeast, arabidopsis, rat and mouse92.  The presence of such hot spots is 
exciting for two reasons. First, an eQTL hotspot that overlaps with a QTL for an 
important clinical trait could provide a biological framework as to how the locus impacts 
that trait while also identifying potentially causal positional/functional candidates for the 
underlying genetic variation.   Secondly, understanding how eQTL arise, and how 
genetic variability in a single locus can co-regulate phenotypic variability in mRNA 
abundance for a large numbers of genes, may shed light on regulation of transcriptional 
control in general. Several models for how eQTL hot spots function have been proposed 
(e.g. Sun et al (2007); Mozhui et al (2008); Wu et al (2008)93-95. 
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 Most eQTL hot spots were discovered by classical QTL mapping techniques in 
segregating crosses in various different tissues. By only modelling genetic variation and 
correlated phenotypes as covariates, the classical mapping algorithms ignore regulatory 
effects among transcripts96. However, the regulation mechanisms for gene expression 
are very complex and dynamic in any biological system. One instance is the regulation 
of expression levels between one gene and another. While traditional QTL mapping 
algorithms give us tremendous insight about complex traits and about genetic regulation 
mechanism102, the statistical modelling underlying the algorithm is far from perfect 
because regulation mechanisms such as regulation between one transcript and another, 
hormonal or neuronal regulations have not been considered at all.  As a result, detection 
of hot spots can be affected by different modelling algorithms. Further, existence of hot 
spots can also be largely influenced by correlation among genes92. The rational is that if 
one transcript is associated with a SNP, then many transcripts that are highly correlated 
with this original transcript may be also be represented as eQTL within the same locus.  
 To further explore this issue, we first performed permutation analysis where 
genotypes were permuted while conserving gene expression phenotypes and the 
internal correlation structure of the data, as proposed by Breitling et al (2008). Through 
this permutation strategy, we tested the hypothesis correlation amongst transcripts can 
lead to the detection of eQTL hotspots. Our results support this hypothesis, in providing 
model-free evidence that nearly all hot spots in our segregating F2 cross arise because 
of correlation structures among transcripts.  
 The most commonly used mouse resources, including the lines used in the 
present study, are from Mus musculus domesticus and harbor only a fraction of the 
genetic diversity of Mus musculus, which is not uniformly distributed108. It is possible that 
large regions of identity-by-descent and repeated SNP distribution patterns across the 
genome due to shared ancestry lead to non-biologically relevant phenotypic correlations 
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in this and other crosses where eQTL hot spots have been reported. Indeed, an early 
study with emerging lines of the Collaborative Cross (CC) mouse resource, which 
captures significantly more genetic diversity with no blind spots and has a much more 
uniform distribution of genetic variation, shows that many common phenotypic 
correlations are disrupted relative to their eight progenitor strains (D Pomp, unpublished 
data). And interestingly, a liver eQTL study in these same emerging CC lines found 
prevalent strong cis eQTL signals, but a complete lack of any eQTL hot spots (G 
Churchill and F Pardo Manuel de Villena, personal communication). While this may 
partially be a result of relatively underpowered studies, it is intriguing to speculate that 
the lack of eQTL hot spots in the emerging CC lines is caused by the natural lack of 
correlation structure amongst transcripts in that diverse resource, supporting the present 
findings where such hot spots are no longer present once this correlation structure is 
uncoupled from the structure of the underlying genetic variation.    
   While permutation analysis showed that hot spots are caused by high correlation 
between transcripts, we also applied NET or structural modelling for an additional robust 
manner to address this issue. We proposed a systematic, network based approach to 
deal with modelling in eQTL studies; note that the NET approach can be useful in many 
other instances where large scale multivariate data are available, but is of particular 
relevance for eQTL mapping. Interestingly, two simulation strategies mimicked the 
experimental results, and stress the relevance of more sophisticated models than those 
currently employed. One of the important advantages of NET over classical modelling is 
that we were able to obtain an increased frequency of cis-eQTL with more significant p 
values, whereas the main picture of eQTL hot spots obtained using traditional eQTL 
mapping was removed. 
 There are drawbacks to the NET modelling, however. Accounting for gene 
correlations alone could not completely remove ambiguities in edge direction and the 
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proportion of false direction of edges is likely high. A further step will be to 
simultaneously integrate gene covariate selection and QTL selection. Integrating QTL in 
the building of gene networks may dramatically improve eQTL power and decrease FDR. 
This approach provides anchors with unambiguous edge directionalities and could help 
to direct the links between phenotypes in the network109, 110. However covariate 
modelling has a profound effect on QTL mapping as we show here. 
 Bagging, and more generally model averaging techniques, provides a sound 
basis to incorporate model uncertainties in the building of such networks. Their statistical 
foundation for the problem of multiple QTL selection has been published recently111 and 
their extension to the problem of multiple co-regulated traits as initiated here should be 
straightforward. Its computational cost is no longer a limitation due to end-user 
parallelization tools and increasing CPU speed112. 
 Structures in data arise from various sources (complex pedigree, historical 
contingencies, biological correlation or analytical biases), and they can have a deep 
impact on QTL discoveries. Therefore to be successful, approaches dealing with QTL to 
decipher gene networks should probably not rigidly fix the QTL found using simple 
models in the first instance, but should modify them accordingly and simultaneously to 
the reconstruction of the gene network. 
 
 
Table 2.1. Descriptive statistics of eQTL hot spots. 
Tissues Locations Total Add Dom Both ICRadd M16add ICRdom M16dom 
Adipose 
MMU2, 63-67cM 
144-153Mb 373 127 33 0 47 80 11 22 
MMU9, 17-21cM 
45-52Mb 166 100 2 0 90 10 0 2 
MMU19, 0-2cM 
3-9Mb 139 36 7 0 19 17 7 0 
Hypothalamus MMU4, 17-21cM 
47-57Mb 233 194 3 0 96 98 1 2 
MMU7, 29-33cM 
78-90Mb 341 50 49 0 14 36 41 8 
MMU17, 39-43cM 
79-83Mb 2112 2054 4 1 1059 995 3 1 
Liver MMU7, 70-72cM 147-151Mb 170 152 0 0 98 54 0 0 
Muscle 
MMU2, 45-49cM 
95 - 107 Mb 288 43 65 1 15 28 40 25 
MMU8, 11-15cM 
30-40Mb 167 10 127 0 7 3 117 10 
MMU15, 16-20cM 
52-59Mb 393 187 4 0 28 159 2 2 
MMU17, 7-11cM 
30-41Mb 298 137 43 1 76 61 22 21 
 
Total: total number of eQTL falling into a 5 cM window during eQTL mapping; Add: number of eQTL with additive effects; Dom: number of 
eQTL with dominance effects; Both: number of eQTL with both additive and dominance effects; ICRadd: the allele from ICR increases the 
expression of a transcript; M16add: the allele from M16 increases the expression of a transcript; ICRdom: the allele from ICR is dominant 
relative to the allele from M16; M16dom: the allele from M16 is dominant relative to the allele from ICR 
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Table 2.2. Number of eQTLs and cis-eQTLs detected at P ≤ 10−3 
 
Tissue Hot spot Model N 
eQTLs 
(%)* N cis-
eQTLs 
(%)† NET/M0‡ cis-
NET/cis-
M0 
Hypo MMU17 M0 1,785 (84.5) 94 (5.3)   
Hypo MMU17 NET 1,149 (54.4) 264 (23.0) 0.64 2.81 
Muscle MMU15+
MMU17 
M0 539 (78.5) 72 (13.3)   
Muscle MMU15+ 
MMU17 
NET 462 (67.2) 104 (22.5) 0.86 1.44 
Muscle MMU15 M0 322 (81.9) 14 (4.3)   
Muscle MMU15 NET 259 (65.9) 43 (16.6) 0.80 3.07 
Muscle MMU17 M0 220 (73.8) 58 (26.4)   
Muscle MMU17 NET 207 (69.5) 61 (29.5) 0.94 1.05 
 
*Percentage of the number of eQTL detected on the total number of genes (see Table 
2.1) 
†Percentage of the number of cis-eQTL detected among the total detected eQTL. QTL 
are annotated as cis-eQTL if they are at most 5cM away from the gene they act on.    
‡Ratio of detected eQTL between the NET model and the M0 model  
  
Figure 2.1. Trans-bands show tissue-specific patterns
Each panel represents eQTL mapping result in a tissue. A red dot indicates a
significant QTL for a transcript. The X-axis denotes the QTL location for a QTL while
the Y-axis describes the physical location of a transcript associated with this QTL.
Diagonal lines indicate the cis-acting QTL and vertical lines suggest the trans-bands.
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Figure 2.2. QTL sharing among four tissues
There are total 14624 transcripts having QTL in all four tissues. Each bar indicates
the number of transcripts of which each transcript has common QTL shared by tissue
number denoted by the X-axis.
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Figure 2.3. Hot spot strength distribution under permutation
We performed 1000 individual permutations. In each permutation, the eQTL mapping
was conducted. The X axis is a vector in which each element represents the maximal
number of eQTL clustering in a 5 cM window after the eQTL mapping from a
permutation. The height of each grey bar indicates the frequency in which the maximal
number of eQTL clustering repeats in one thousand permutations. The red bar shows
the observed maximal number of eQTL clustering in a 5 cM window without
permutation. The inlet table on each panel shows the maximal number of eQTL
clustering and the probability to observe this number without permutation.
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Figure 2.4. Genome-wide profiles of significant –log10 p (P ≤ 10 –3) for the two
tissues.
The x-axis is the location in cM of the QTL, and the y-axis, the position of the gene in
Mb. Only regions with P ≤ 10 –3 are plotted. The model used here is different to the
one used for Fig 2.1 and analyzed only a subset of the data shown in Fig 2.1.
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Figure 2.5. Ratio of the number of all eQTLs (A) or cis-eQTLs (B) between
models M0 and NET given the significance threshold on the eQTL scores.
Hypothalamus results are the plain line, the muscle MMU15 results are the dashed
line, and the dotted line refers to the muscle MMU17 results. A ratio of 1 means
neither gain nor loss in the discovery of eQTLs. A ratio > 1 means that a larger
number of eQTLs was detected with the NET model. The eQTL distant of at most 5
cM of the gene they act on are annotated cis-eQTL.
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Figure 2.6. Accumulation curves of cis-eQTL given the thresholding distance in
M0 and NET models.
The plain line is the M0 model and the dashed line is the NET model. The x-axis is
the distance (cM) between the QTL and the gene, and the y-axis, the number of eQTL
declared cis (The QTL that are located closer than or equal to the distance). The gray
vertical bar shows the used threshold of 5 cM. The increase of cis-eQTL detected
using the NET model compare to the classical M0 model is consistent whatever the
linkage distance that would be chosen.
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Figure 2.7. Genome-wide profiles of significant –log10 p (P ≤ 10 –3) for the 2
simulations.
A and B) Simulation was done with gene regulatory network. C and D) Simulation of
10 blocks of 100 highly correlated gene expression levels. A and C) Classical eQTL
mapping. B and D) NET mapping. The x-axis is the location in cM of the QTL, and the
y-axis, the position of the gene in cM. Only regions with P ≤ 10 –3 are plotted.
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CHAPTER III 
 
GENETIC ARCHITECTURE UNDERLYING VARIATION IN EXTENT AND 
REMODELING OF THE COLLATERAL CIRCULATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The contents of the following chapter were originally published by the open 
access publisher Biomed Central (3)
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A. Abstract 
Rationale. Collaterals are arteriole-to-arteriole anastomoses that connect adjacent 
arterial trees.  They lessen ischemic tissue injury by serving as endogenous bypass 
vessels when the trunk of one tree becomes narrowed by vascular disease.  The 
number and diameter (“extent”) of native (pre-existing) collaterals, plus their amount of 
lumen enlargement (growth/remodeling) in occlusive disease, show remarkably wide 
variation among inbred mouse strains (eg, C57BL/6 and BALB/c), resulting in large 
differences in tissue injury in models of occlusive disease.  Evidence suggests similar 
large differences exist among healthy humans. 
Objective. To identify candidate loci responsible for genetic-dependent collateral 
variation. 
Methods and Results. Cerebral collateral number and diameter were determined in 221 
C57BL/6-x-BALB/c F2 progeny, followed by linkage analysis to identify quantitative trait 
loci (QTL) for collateral number and diameter.  Four QTL were obtained for collateral 
number, including epistasis between two loci.  A QTL that was identical to the strongest 
QTL for collateral number on chromosome 7 (LOD=29, effect size=37%) was also 
mapped for collateral diameter (LOD=17, effect size=30%).  Chromosome substitution 
strain analysis confirmed this locus.  We also obtained a unique QTL on chromosome 11 
for collateral remodeling after middle cerebral artery occlusion.  Association mapping 
within the chromosome 7 QTL interval using collateral traits measured for 15 inbred 
strains, delineated 172k (p=0.00002) and 290k (p=0.0004) base-pair regions on 
chromosome 7 containing 2 and 7 candidate genes, respectively. 
Conclusions. We conclude that collateral extent and remodeling are unique, highly 
heritable complex traits, with one QTL predominantly affecting native collateral number 
and diameter. 
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B. Introduction 
 Atherosclerotic, atherothrombotic and thromboembolic occlusive vascular 
diseases constitute the primary cause of morbidity and mortality in developed countries.  
Many physiological systems are concomitantly recruited, albeit with significant inter-
individual variation, which lessen the accompanying ischemic tissue injury.  Among 
these, three vascular protective mechanisms are paramount: (1) the number and 
diameter of arteriole-to-arteriole anastomoses present in the tissue before the onset of 
disease that cross-connect occasional distal-most arterioles of adjacent trees (ie, the 
“native collateral extent”), (2) an anatomic increase in lumen diameter and wall thickness 
of these vessels caused by obstruction of flow to one of the trees—a process termed 
collateral remodeling, collateral growth or arteriogenesis, and (3) ischemic angiogenesis, 
ie, the sprouting of additional capillaries1, 7, 11, 113-115.  Arteriogenesis, which requires 
days-to-weeks to achieve up to an approximately 10-fold increase in diameter depending 
on tissue and species, occurs when perfusion of an adjacent tree is chronically reduced 
below a critical level.  This increases flow-dependent shear stress on collateral 
endothelial cells, which in turn initiates an inflammatory-like remodeling process.  It is 
becoming recognized that the extent of the native collateral circulation and collateral 
remodeling have significantly greater impact on restoring blood flow to ischemic tissue 
than does angiogenesis—which can only increase dispersion of whatever flow is 
provided by the collateral network1, 113, 115. 
 The severity of the clinical manifestations of occlusive vascular diseases, ie, 
myocardial infarction, stroke and chronic ischemic disease of the heart, brain and lower 
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extremities, have long been known to vary widely among individuals.  This is presumably 
due to variation in environmental influences and risk factors as well as genetic mutations 
and polymorphisms affecting the extant pathological and physiological processes.  
Although much effort has focused on identifying the sources of this variation, the 
possibility that differences in extent of the native collateral circulation exist among 
healthy individuals and contribute significantly when disease strikes has, until recently, 
received little attention.  Meier and colleagues24 found, using an index primarily 
dependent on collateral density and diameter, that coronary collateral conductance 
varied by approximately 10-fold in healthy human subjects.  Since these subjects lacked 
coronary artery disease, the variation could not be affected by differences in stenosis-
induced collateral remodeling.  Studies employing dynamic angiography in patients with 
acute stroke from middle cerebral artery obstruction, where differences in remodeling 
can again be ruled out due to the acute nature, suggest that wide variation in native 
collateral conductance is also present in the cerebral circulation27-30.  Likewise, evidence 
exists for significant variation in collateral extent in the peripheral limbs of healthy 
individuals116, 117. 
 Recent studies in mice suggest that a substantial amount of this variability 
arises from naturally occurring polymorphisms in genetic loci involved in molecular 
pathways directing formation of the collateral circulation, which occurs late embryonically 
and early postnatally in mice38.  Native collateral density and diameter evidenced large 
differences in multiple tissues in adult C57BL/6 and BALB/c mouse strains16, 118, 119.  In 
fact, C57BL/6 and BALB/c mice have the largest extremes in collateral extent in the 
cerebral circulation among 15 strains, for example exhibiting a greater than 30-fold 
difference in collateral density16.  Importantly, these differences in collateral extent in the 
cerebral circulation are shared qualitatively by other tissues, including skeletal muscle 
and intestine16, 34, 37.  Moreover, the rank-order of cerebral collateral extent among 15 
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mouse strains closely predicts the rank-order of severity of stroke (infarct volume) after 
permanent middle cerebral artery occlusion12.  This finding establishes a major role for 
genetic variation in the extent of the collateral circulation in determining variation in 
severity of ischemic tissue injury.  Interestingly, collateral remodeling during stroke also 
evidenced significant variation, but with a strain-specific pattern significantly different 
from the pattern associating infarct volume with collateral extent12.  This suggests that 
different pathways are responsible for collateral formation versus collateral remodeling, 
and that genetic variation in them is likely to be mediated by different loci. 
 Nothing is known about the genetic loci responsible for the remarkably wide 
variation in native collateral extent and collateral remodeling described above.  However, 
studies employing gene targeting methods have identified two genes, Vegfa and Clic4¸ 
whose expression positively regulates collateral formation in the embryo and thus 
collateral extent in the adult; one of these (Vegfa) also participates in collateral 
remodeling34, 37.  Hence, polymorphisms in these genes are a priori candidates for 
causing variation in collateral circulatory function.  Identification of the alleles underlying 
individual variation in collateral extent and remodeling is important not only to help define 
the responsible signaling pathways for these two processes, but also to allow 
assessment of risk-severity if occlusive vascular disease develops and to permit 
stratification of individuals enrolled in clinical trials testing new collaterogenic therapies.  
Therefore, in the present study we sought to identify genetic loci governing variation in 
collateral extent and remodeling.  To achieve this goal we created 243 F2 mice 
intercrossed between the C57BL/6 and BALB/c strains and performed linkage analysis 
to identify quantitative trait loci (QTL).  We then used association mapping among 15 
inbred strains to identify candidate genes responsible for variation in collateral function. 
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C. Materials and Methods 
Animals 
 F1 progeny obtained from reciprocal matings of C57BL/6J (B6) and BALB/cByJ 
(BALB/c, Bc) were mated to produce an F2 population.  Chromosome substitution 
strains were C57BL/6J-Chr7A/J/NaJ (CSS7) and C57BL/6J-Chr17A/J/NaJ (CSS17). 
 
Phenotyping 
 Mice were subjected to right-side middle cerebral artery occlusion (MCAO) and 
collateral number and diameter measured 6 days later12.  To image the pial circulation, 
the rostral vasculature was maximally dilated, filled with yellow MicrofilTM with viscosity 
adjusted to prevent capillary filling, and fixed (paraformaldehyde).  Collaterals 
connecting the anterior cerebral (ACA) and middle cerebral (MCA) artery trees in both 
hemispheres were digitally imaged.  Cortical territories supplied by the MCA, ACA and 
PCA trees were determined12.  ANOVA or t-tests were used together with Bonferroni 
correction where appropriate. 
 
DNA isolation and genotyping 
 Tail genomic DNA was genotyped using the 377-SNP GoldenGate genotyping 
array (Illumina, San Diego, CA).  Manual genotyping was done for one marker 
(rs32420445).  SNP positions were obtained from Build 37.1 of the NCBI SNP database. 
 
Linkage analysis 
 Collateral traits are defined as collateral number, diameter and "conductance" 
(number-x-diameter) measured in the left (non-occluded) hemisphere.  The remodeling 
trait is the average fold change in collateral diameter between right and left hemisphere 
6 days after MCAO.  These traits in the F2 population were subjected to linkage analysis 
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using single and multiple QTL models in the R statistical program.  Thresholds for 
significant and suggestive QTL were defined as P=0.05 and P=0.63, respectively. 
 
Association mapping 
 The efficient mixed model association algorithm (EMMA; 21) was applied in R 
to collateral number measurements on 15 inbred strains, 8-10 individuals each, obtained 
previously12, 79 (see Supplemental figure 3.1). 
An expanded Materials and Methods section is available in the Online Data Supplement 
at http://circres.ahajournals.org. 
 
 
D. Results 
Native collateral trait differences between B6 and Bc strains are heritable   
 We previously showed in multiple tissues that Bc mice have smaller collateral 
number and diameters than B6 mice16.  This is striking in the pial circulation, where Bc 
mice average less than one collateral per hemisphere, compared to 9 in B6.  We further 
showed that among 15 strains Bc had the lowest pial collateral number and near-lowest 
diameter (13µm)12.  Among those strains, B6 has the largest collateral diameter (23µm), 
and nearly the largest number of pial collaterals.  Therefore, B6 and Bc were chosen for 
identification of QTL for native pial collateral number and diameter, for a quasi-index of 
total collateral “conductance” (defined as number-x-diameter) and for increase in 
collateral diameter (remodeling) induced by MCAO.  MCAO in one hemisphere does not 
alter collateral number or diameter in the other, non-operated hemisphere12.  After 
exclusion of 22 individuals for poor filling or other technical problems, 221 F2 mice were 
analyzed for native collateral properties and 190 for remodeling.  The mice were 
genotyped at 228 informative SNPs across the genome (see Methods). 
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 Cerebral arteriograms from non-operated B6 and Bc mice are shown in Figure 
3.1A.  The entire population of MCA-ACA collaterals is confined to the pial surface, 
aiding direct quantification12.  The Bc brain shown, with no pial collaterals, is typical of 
most Bc mice.  Previously reported values for collateral diameter and number in B6 and 
Bc12, 16 were confirmed here: 9 and 22.5um in B6, 0.5 and 12.5um in Bc) (Figure 3.1B). 
 All 3 collateral parameters were intermediate in the F1 population between 
those for B6 and Bc (Figure 3.1B) although closer to those for B6.  Collateral diameter 
and conductance in F1 mice were significantly lower than in B6 (p<0.05) but were still 
larger than the average of B6 and Bc values.  For collateral number, the trend toward 
fewer than in B6 was not significant.  Thus, collateral traits in B6 are semi-dominant over 
Bc. 
 
Genome-wide single QTL mapping detects a major effect on chromosome 7 
(Canq1) for native collateral traits 
 In the F2 population, all 3 collateral traits were approximately normally 
distributed, indicative of polygenic traits, with the distributions containing suggestions 
that they may be sums of multiple normal distributions (Figure 3.1C).  These traits were 
independent of sex, parental origin, or body weight (Supplemental figures 3.2, 3.3). 
Variation in collateral traits was also independent of body weight among 15 inbred 
strains12.  Collateral number and diameter were minimally correlated (r2=0.13), 
confirming previous results12 and suggesting that number and diameter are largely 
independent traits (Supplemental figure 3.4). 
 The phenotype-genotype data were subjected to genome-wide LOD score 
profiling using the single QTL model in R/QTL.  This identified a single, highly significant 
locus on distal chromosome 7 for all 3 collateral traits (LOD scores of 21, 17, and 27 for 
number, diameter, and conductance, respectively; genetic (heritable) effect sizes>30% 
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for all three) (Figure 3.2A; Supplemental table 3.1).  The peak is located 0.5cM 
telomeric to marker rs13479513 (134.25Mb; Figure 2A inset).  The 95% confidence level 
is 62-67cM, which is estimated to correspond to 132.4-135.8Mb in physical location.  
The single QTL model also identified a significant QTL (genome-wide 0.05 significance 
level) for collateral number on chromosome 1, two suggestive QTL (genome-wide 0.63 
significance level) on proximal chromosome 6 and chromosome 10 for number, and two 
suggestive QTL on chromosomes 1 and 10 for conductance (Figure 3.2A). 
 
Additional QTL and epistasis identified by genome-wide multiple QTL mapping 
 Experiments using haplo-insufficient and null gene targeted mice have shown 
that Vegfa, Flt1 (VEGFR1) and Clic4 expression levels are strong positive determinants 
of collateral number34, 37, 39.  However, our single QTL analysis revealed no QTL in the 
regions of these genes (Figure 3.2A), possibly due to the predominant major effect on 
chromosome 7.  Moreover, the multiple suggestive QTL identified using the single QTL 
model suggest a complex genetic architecture may underlie variation in native collateral 
extent.  Also, a single QTL model cannot detect epistasis.  To address these issues, we 
subjected the data to genome-wide multiple QTL profiling with increased statistical 
power using the Stepwiseqtl function in R/QTL. 
 As shown in Figure 3.2B, this analysis confirmed and strengthened the QTL on 
chromosome 7 for collateral number, the LOD score improving from 21 to 29 and the 
effect size increasing from 32% to 37%.  It also gave a strong QTL (LOD score 13) at 
45cM (90Mb) on chromosome 1, which presumably represents the same genetic 
influence as the weaker QTL on chromosome 1 (LOD score 3.8, 49cM) in the single QTL 
analysis.  Multiple QTL mapping also identified significant loci on chromosomes 3 and 8 
for collateral number (LOD scores of 7 and 5, resp.), and interaction between the QTL 
on chromosomes 1 and 3 (LOD score 7).  Suggestive QTL on chromosomes 6 and 10 
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were not confirmed.  These results are summarized in Figure 3.2B; the inset shows the 
final model for collateral number.  We have named the QTL according to convention by 
descending order of LOD score as Canq1-4 (collateral artery number QTL), Cadq1 
(diameter), and Cacq1-2 (“conductance”).  Table 3.1 summarizes effect sizes, the 
modes of inheritance (additive or dominant) and their degree, and the statistical 
significance.  We also detected slight segregation distortion between proximal 
chromosome 10 and distal chromosome 6 (p<0.03 by Chi-square test).  One possible 
explanation for these findings is that linkage disequilibrium exists between the loci on 
chromosomes 6 and 10 and the major effect on chromosome 7, a condition controlled 
for by multiple QTL analysis. 
 Like the single QTL analysis, multiple QTL analysis failed to find any effect of 
Vegfa, Fllt1, or Clic4.  To search exhaustively for potential epistases with these genes, 
we fixed all main effects and the interaction, then searched for interaction between 
Canq1 and any other locus.  No significant interaction was found (Supplemental figure 
3.5). 
To evaluate the genetic effects of the QTL on chromosome 7 for the 3 collateral traits, 
the average phenotype values were plotted against genotype for mice grouped by 
genotype at the marker nearest the peak, rs13479513.  Mice homozygous for the B6 
allele or heterozygous (B6-Bc) did not differ significantly from B6 or the F1 population, 
respectively, in any of the traits (Figure 3.3A, B).  The Bc-Bc group also did not differ 
from the Bc parental in diameter.  Thus, these phenotypes are largely determined by the 
single B6 allele when present.  For collateral number, however, Bc-Bc F2 mice had 
significantly more pial collaterals than the parent Bc (3.9 vs. ≤0.5, p<0.001).  The same 
is true of the derived parameter, “conductance” (56 conductance units vs. 12 for Bc, 
p<0.05).  In addition, in our study of 15 inbred strains (18), Bc was significantly lower in 
pial collateral number than the two closest strains (Bc, 0.2 collaterals per hemisphere; 
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SWR, 1.3, p=0.0004 vs. Bc; AKR, 1.7, p<0.0001 vs. Bc; Supplemental figure 3.1).  
These results suggest that additional loci, possibly unique to Bc among these strains, 
are responsible for the very low numbers of collaterals in Bc mice and are consistent 
with our finding of 3 additional QTL for collateral number but not diameter. 
 To see phenotypic effects, the genotype at a hypothetical marker located 
exactly at the peak of each of the QTL on chromosomes 1, 3 and 8 was imputed and the 
mice grouped according to these genotypes (Figure 3.3B).  This shows that the QTL on 
chromosome 1 acts in the same direction as that on chromosome 7 (ie, to favor greater 
number and conductance in B6; first and third panels in Figure 3.3B), while those on 
chromosomes 3 and 8 act in the other direction, albeit weakly (first panel). 
 
The major effect of chromosome 7 is confirmed with chromosome substitution 
strains (CSS) 
 The inbred strain A/J is similar to Bc in haplotype structure under Canq1.  It is 
also similar in hindlimb necrosis and recovery of hindlimb perfusion following femoral 
artery ligation17 and infarct volume after MCAO18 (see Discussion).  These phenotypic 
characteristics, which gave a QTL in the same position as Canq1, were recapitulated in 
both of these studies in the strain C57BL/6J-Chr 7A/J/NaJ (CSS7), in which chromosome 
7 in the B6 stain has been replaced by chromosome 7 from A/J.  We therefore measured 
native collateral traits for CSS7.  New data on A/J mice (n=8) in this study confirmed our 
previous results12; A/J has 65% fewer pial collaterals than B6, and CSS7 is not 
statistically different from A/J (Figure 3.4A).  CSS7 has slightly larger collateral diameter 
than Bc (12.6um vs. 8.6um for A/J, p<0.003), but diameter is substantially smaller than 
in B6 (12.6 vs. 24.6um for B6, p<0.001; Figure 3.4B).  Similarly, CSS7 has 70% lower 
conductance than B6, compared to 86% lower for A/J and 98% lower for Bc (Figure 
3.4C).  Hence, CSS7 largely mimics Bc in all 3 native collateral traits, as it does for 
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necrosis in hindlimb ischemia and cerebral infarct volume following MCAO17, 18.  
However, the significant difference between CSS7 and A/J for diameter and 
conductance and trend toward significant difference for number suggest that loci on 
additional A/J chromosomes influence collateral traits.  Failure to find such evidence in 
previous studies using CSS7 analysis for recovery of hindlimb perfusion and necrosis 
score17 and infarct volume18 may arise because these downstream traits are removed 
from the underlying physiological mechanisms—that are dominated by native collateral 
extent and collateral remodeling. 
 Different amounts of cortical territory supplied by each of the main arteries 
(MCA, ACA, and PCA) are determinants of infarct volume after MCAO12 and could, in 
principle, be determinants of pial collateral extent.  And A/J mice have a larger 
percentage MCA territory that could potentially confound interpretation of the A/J and 
CSS7 data12.  Therefore, we also examined tree territories.  The percentage MCA 
territory in CSS7 mice was not different from that of B6 and Bc mice (Figure 3.4D).  In 
contrast, chromosome 17 (see below) transferred a significant part of the enlarged MCA 
territory phenotype of A/J to B6, consistent with the notion that loci on chromosomes 
other than 7 are responsible for the enlarged MCA tree in A/J mice.  These data are 
consistent with our previous finding that collateral number and diameter show essentially 
no correlation with tree territory (r2=0.05 and 0.01, resp)12. 
 Since no QTL was found on chromosome 17 for collateral traits, cerebral 
infarct volume18, or necrosis score and recovery of perfusion in a hindlimb ischemia 
model17, CSS17 was also examined for pial collateral traits as a negative “control” to 
validate the CSS approach.  CSS17 was not different from B6 in collateral number and 
conductance (Figure 3.4A, C).   However, collateral diameter was significantly lower in 
CSS17 than in B6 (20um vs. 24.6um, p<0.0002), but it was still larger than in A/J by a 
substantial amount (20um vs. 8.6um, p<0.0001).  These data suggest that the 
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preparation of the CSS strains did not, per se, cause the Bc-like low values for native 
collateral traits found in CSS7, thereby reinforcing the conclusion that the main effect for 
low collateral number, diameter, and conductance resides on chromosome 7.  The 
significant reduction in collateral diameter in CSS17 indicates that chromosome 17 of 
A/J mice harbors a genetic factor(s) that negatively affects this trait when introgressed 
onto the B6 background. 
 Importantly, the above findings offer a physiological basis for the previously 
identified QTL on chromosome 7 linked to hindlimb ischemia and cerebral infarct 
volume17, 18, ie, a gene variant(s) that confers variation in native collateral extent. 
 
Cell-cell signaling and immune response pathway genes are enriched in Canq1 
 We subjected all genes in the Entrez database within the 95% confidence 
interval of Canq1 (132.3-135.8) to Ingenuity pathway enrichment analysis (Ingenuity 
Systems, Redwood, CA).  After adjustment for multiple-testing errors (Benjamini-
Hochberg adjusted p value <0.05), enrichment was found for cell-cell signaling and 
immune response genes (Supplemental figure 3.6).  These findings are supported by 
potential candidate genes responsible for variation in collateral extent revealed by 
association mapping (below). 
 
Association mapping links pial collateral traits to a narrow region within Canq1 
 Given the strength of the QTL on chromosome 7, one can speculate that 
inbred strains that share haplotype identity with B6 will have a B6 collateral phenotype, 
and similarly for Bc.  Thus, by comparing the structure within the region of the QTL 
across multiple inbred strains, it should be possible to narrow the region harboring the 
genetic element(s) responsible for the QTL.  However, as extensively discussed by Kang 
et al.79, the population structure and relatedness among inbred strains lead to high false 
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positive rates and low statistical power.  To circumvent these problems, we applied the 
efficient mixed model association (EMMA) algorithm designed by Kang et al. to the 134 
individuals (8-10 per strain) of the 15 inbred strain set we studied previously 
(Supplemental figure 3.112).  The relatedness among inbred strains was modeled as a 
random effect.  The kinship matrix (covariance matrix) was calculated using densely 
imputed SNPs with confidence levels of ≥0.9 obtained from the Jackson Laboratory web 
site (http://phenome.jax.org/pub-gi/phenome/mpdcgi?rtn-snps/download).  Upon 
interrogating each of the 41,000 SNPs in the 127-142Mb region on chromosome 7, a 
tight group of 18 SNPs at 132.356 to 132.529Mb was found to have the greatest 
significance (p=2.2x10E-5;  Figure 3.5, group A).  This narrow region overlaps the 
proximal boundary (132.4Mb) of the previously defined 95% confidence interval.  This 
concordance strongly suggests that the 172 kb region harbors genetic variation that 
determines native collateral extent.  Two predicted genes fall in this region (Table 3.2).  
Inclusion of the next most significant set of SNPs (p<4.2x10E-4; Figure 3.5, group B), 
expands the region telomerically to 132.817, to include a total of 9 genes (Table 3.2). 
 
LOD score profiling for collateral remodeling identifies a QTL on chromosome 11 
 Obstruction of the trunk of a main artery tree cross-connected to an adjacent 
tree by collaterals, as in MCAO, induces sustained unidirectional flow and shear stress 
in the collaterals38.  This induces the collateral vessels to increase their lumen diameter 
and wall thickness, a process called outward remodeling or arteriogenesis that can be 
quantified as a fold change in diameter in the operated hemisphere relative to the non-
operated hemisphere113.  We showed that in mice this process occurs during the first few 
days after MCAO, and that the amount of remodeling is subject to strong genetic 
influence12.  Herein, we examined remodeling 6 days after MCAO because at this time 
remodeling had reached a maximum in B6 mice but was considerably less in Bc12.  A 
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genome-wide scan using the single-QTL model for fold change revealed a significant 
QTL identical to Canq1 and a weaker QTL on chromosome 10 (Figure 3.6)  The 
relationship between velocity and cross-sectional area proscribes that larger diameter 
collaterals will have lower fluid shear stress after ligation (eg MCAO), leading to less 
shear-induced remodeling.  In support of this, a highly significant inverse correlation was 
obtained for collateral remodeling and baseline diameter (Figure 3.6), in agreement with 
previous results12.  Hence, diameter is a covariate for remodeling.  When set as such in 
the statistical model, the QTL on chromosomes 7 and 10 were lost, and a significant 
QTL on chromosome 11 (LOD score 3.5) was obtained (Figure 3.6, blue curve; Table 
3.1).  These results are consistent with the expectation that genes regulating collateral 
formation (ie, native number and diameter) in the embryo38 are likely to differ from those 
regulating remodeling in the adult1. 
 
 
E. Discussion 
 This study sought to identify the genetic determinants responsible for the wide 
variation in the number and diameter of native (pre-existing) collaterals in healthy tissue 
of inbred mice1, 12, 16, 34, 37, 38, 118, 119 and potentially in humans27-30, 116, 117, and collateral 
remodeling after arterial occlusion16, 38, 118.  We recently reported that these traits in the 
brain vary widely with genetic background, with C57BL/6 (B6) and BALB/c (Bc) mice 
being at the two extremes, and that this variation strongly correlates with infarct volume12.  
In the present study, we performed genome-wide linkage analysis in an F2 cross 
between B6 and Bc mice using collateral number, diameter and conductance as 
quantitative traits and identified a major locus on chromosome 7 that modulates 
collateral extent.  Further evidence for the involvement of this locus was supported by 
use of chromosome substitution strains.  We also identified a locus on chromosome 11 
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for collateral remodeling after setting the diameter at baseline as a covariate.  High 
density association mapping was then used to narrow down the chromosome 7 QTL to a 
172 kb region containing 9 candidate genes.  Importantly, the major QTL on 
chromosome 7 is at the same locus as a previously reported QTL linked to hindlimb 
ischemia17 and cerebral infarct volume18.  This identification of a common QTL on 
chromosome 7 is very robust, having been made for physiologically linked but quite 
distinct phenomena (native collateral extent, cerebral infarct volume and hindlimb 
necrosis/perfusion recovery) in multiple tissues (cerebral pial circulation, cerebral cortex 
and skeletal muscle).  In the previous papers, the underlying physiological basis was not 
identified.  The present findings strongly suggest that that physiological basis is 
genetically determined variation in native collateral extent.  As such, our results focus 
attention on the possibility that a major component of the amount of tissue injury in 
response to arterial obstruction in the brain, heart and peripheral limbs may be a 
person’s genetic predisposition influencing the extent of the collateral circulation. 
 In the study by Dokun et al17, the magnitudes of necrosis score and recovery of 
perfusion assessed 21 days after femoral artery ligation depended in large part on both 
collateral extent and collateral remodeling, although additional mechanisms could 
contribute1, 7, 11, 12, 16, 34, 37, 113-115, 119.  However, infarct volume assessed 24 hours after 
MCAO18, when only minimal remodeling of pial collaterals could have occurred, depends 
to a larger degree on native collateral extent.  Given the dependence of shear stress-
induced remodeling on collateral diameter, our results argue strongly that variation in 
native collateral extent exerted by the chromosome 7 locus is the major biological 
substrate underlying both previously reported QTL17, 18.  This also provides a 
physiological mechanism—collateral formation during the perinatal period—on which to 
prioritize candidate genes and genetic elements for known or suspected involvement.  
Furthermore, since B6 and Bc strains have high and low native collateral extent, 
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respectively, in pia, skeletal muscle, and intestine16, these results suggest that the same 
genetic determinants will apply to variation in collateral function in other tissues. 
 Infarct volume is inversely related to the prevailing arterial pressure after 
cerebral artery occlusion (since arterial pressure is the driving force for collateral 
perfusion), which could potentially impact interpretation of our results.  As previously 
noted by Keum and Marchuk for Civq118, the centromeric tail of Canq1 overlaps the 
telomeric end of a syntenic rat chromosome 1 locus for blood pressure and infarct 
volume120.  However, Yao et al120 found that stroke-prone, spontaneously hypertensive 
rats (SPSHR) made congenic for this locus from the normotensive WKY rat showed both 
lower blood pressure and smaller cerebral infarct volumes after MCAO.  The latter effect 
is opposite to what is expected, suggesting that secondary changes in vascular structure, 
smooth muscle tone or pressure-independent genetic factors also linked to the rat locus 
might instead be involved120.  In addition, the location of the telomeric end of the 
introgressed piece corresponds to 128 Mb in mouse chromosome 7, which is well 
upstream of the peaks suggested by EMMA and the multiple QTL analysis.  Finally, 
arterial pressures in Bc and B6 mice are virtually identical, whether measured in the 
anesthetized or conscious state121-124.  Thus, these findings do not support arterial 
pressure differences as a physiological mechanism underlying the common QTL 
identified on chromosome 7 in the present or previous studies17, 18. 
 Majid et al.33 found no significant difference in blood flow velocity between the 
B6 and Bc strains measured with a laser Doppler probe in an estimated 1mm3 of tissue 
in the “core of the MCA ischemic territory” 10 minutes after MCAO, and concluded that 
non-hemodynamic variables (ie, including no differences in collateral extent) are 
responsible for the different infarct volumes in the two strains.  However, several 
considerations call this conclusion into question: Values trended lower for the Bc mice.  
The Doppler probe that was used measures velocity rather than flow; velocity can 
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remain unchanged despite reduced flow if diameter also declines (eg, by passive 
collapse after MCAO), measurement of overall cerebral blood flow velocity in the MCA 
territory from a single-point probe is unreliable (eg, 24).  Lastly, the Doppler signal 
includes blood flow in the dura mater, which is not supplied by the MCA. 
Canq1, LSq-1 (22) and Civq118 are broad loci that contain many genes.  The gene list 
under LSq-1 was reduced by interval-specific haplotype association mapping based on 
the criterion that haplotypes under the QTL would be identical in Bc and A/J mice and 
different from B6 (22).  For cerebral infarct volume (Civq1), the criterion was expanded 
to include strain SWR, further reducing the list of candidate genes to only 12 in a 10 Mb 
region, from 132.47 (49334400M02RIK) to 142.37 Mb (Dock1)18.  These analyses also 
apply to Canq1.  However, to further refine this region we applied the recently described 
efficient mixed model association method (EMMA; 21) to 41,000 known, high quality 
SNPs in the 15 Mb region.  Low statistical power and high false-positive rate can arise in 
haplotype mapping in mice due to genome-wide application, limited sample size, and 
lack of control for population structure79.  Therefore, we confined our association 
mapping to 127-142 Mb (Canq1) and native collateral number from 15 inbred strains 
(n=8-10 of each strain12).  We also used dense markers to infer the kinship matrix for the 
15 strains.  Finally, we applied the resultant kinship matrix to the EMMA algorithm to 
model population structure as a random effect to account for the population structure 
problem.  This analysis pointed to a narrow region encompassing 9 genes, of which 7 
failed to satisfy the haplotype criterion applied by Dokun et al. and by Keum and 
Marchuk.  Thus, only one gene (4933440M02RIK, a predicted gene with EST support 
but no annotation) is common to the list of Keum and Marchuk and the list suggested by 
EMMA.  There are no known miRNAs in the high-probability 9-gene EMMA region, nor is 
it known whether other classes of regulatory DNA or RNA elements (eg, long non-coding 
RNAs) are present.  Future work will be needed to identify the genetic element(s) 
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underlying the major QTL on chromosome 7 and to define the molecular pathways 
controlling collateral formation in the embryo and thus the wide variation in the adult. 
Several genes with known influences on native collateral extent or collateral remodeling 
were not detected in our analysis.  Experiments using mice haplo-insufficient or null for 
Vegfa, Flt1 (VEGFR1) and Clic4, have shown that these molecules are strong positive 
determinants of perinatal collateral formation and maturation and thus native collateral 
number and diameter in the adult34, 37, 39.  Furthermore, induction of VEGF-A expression 
is significantly lower in Bc compared to B616, 34, 37, 38, 125, 126 (expression of Flt1 and CLIC4 
have not been examined in Bc versus B6).  However, we found no QTL in the regions of 
these genes in either single or multiple QTL analysis.  In addition, no interaction between 
Canq1 and any other locus was found when all main effects and the epistasis between 
Canq2 and Canq3 were fixed.  This outcome was expected for Vegfa and Clic4, since 
these genes and their flanking sequences are essentially identical in B6 and Bc.  The 
Flt1 gene and flanking sequences are different between B6 and Bc, and are identical in 
Bc and A/J.  However, whether this has functional consequences in the context of the B6 
and Bc backgrounds is not known.  One or more of the genetic elements underlying 
Canq1-Canq4 may act in a weak trans manner to influence expression of VEGF-A, Flt1 
or CLIC4, or other molecules involved in collateral formation may compensate for 
deficiencies in this pathway in Bc mice.  Additional studies will be required to determine 
the role(s) of variants underlying the QTL identified in the present study. 
 Ingenuity pathway analysis within the 95% confidence interval of Canq1 found 
enrichment for immune response genes, and IL4 receptor alpha and IL21 receptor were 
among the 9 genes in the high significance region identified by EMMA association 
mapping.  While collateral remodeling is known to be highly dependent on the immune 
system7, 11, 113-115, no studies have examined whether collateral formation and maturation 
during the perinatal period, which determine native collateral number in the adult, involve 
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immune cell function.  Van Weel et al.127 found evidence suggesting involvement of the 
known difference in natural killer cell (NKC) function in B6 versus Bc mice—associated 
with a different haplotype on distal chromosome 6 involving the NKC gene complex 
locus128—in the difference in recovery of blood flow after femoral artery ligation in these 
strains (which is dependent, in large part, on native collateral extent and collateral 
remodeling).  However, this group recently reported, using congenic mice with this locus 
introgressed into the opposite strain, that the difference in native collateral number does 
not depend on the NKC locus129.  This is consistent with our finding of no QTL on distal 
chromosome 6.  It also is consistent with lack of agreement of this chromosome 6 
haplotype in 8 inbred mouse strains with native collateral number in these same strains12, 
129.  Our results linking variation in remodeling of pial collaterals to its dependence on 
initial collateral diameter and thus the chromosome 7 locus, plus the diameter-
independent locus on chromosome 11, are not congruent with a role for chromosome 6 
in collateral remodeling.  Van Weel et al did not examine if mice congenic for the 
chromosome 6 NKC locus show transference of differences in the remodeling phenotype. 
 We identified different genetic architectures for variation in collateral number, 
diameter and collateral remodeling.  Native collateral number and diameter in young 
adult mice (eg, 10 week-old as studied herein) are determined by two processes—
collateral formation which occurs late embryonically after the general circulation has 
formed—and collateral maturation which occurs during the first three postnatal weeks38.  
The former involves sprouting of a unique plexus of arterial-fated endothelial cell tubes, 
while the latter involves pruning away of a portion of these nascent collaterals, followed 
by lumen enlargement and smooth muscle cell investment of those that are retained1, 38.  
Collateral remodeling, which occurs in obstructive disease in the adult, involves a 
complex signaling and restructuring process7, 11, 113-115.  Although much is known about 
the molecular signaling pathways directing collateral remodeling, almost nothing is 
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known about those directing formation and maturation1.  The very different mechanisms 
and times of occurrence of the three processes suggest they are guided, at least in part, 
by genes unique to each.  In support of this, collateral number and diameter shared a 
common QTL (Canq1), while number was linked to three additional QTL, and a QTL for 
remodeling was found on chromosome 11.  In addition, collateral number, diameter and 
amount of remodeling have unique rank-orders among 15 inbred strains12.  Importantly, 
all three traits are critical determinants of the severity of stroke and ischemic disease of 
the heart and other tissues1. 
 In conclusion, our findings show that the extent and remodeling of the native 
collateral circulation is subject to wide variation that is due, primarily, to a remarkably 
strong polymorphism on chromosome 7, with smaller contributions from several 
additional QTL.  These findings provide the underlying physiological basis for a recently 
reported QTL at the same locus on chromosome 7 linked to severity of hindlimb 
ischemia and cerebrovascular stroke17, 18.  Variation in collateral traits reflect yet-to-be 
identified genetic and environmental factors that impact formation and maturation of 
collaterals, maintenance of them during natural growth to adulthood and subsequent 
aging, and collateral remodeling in obstructive disease.  Our findings establish a 
foundation for future studies to identify the alleles and molecular pathways that direct 
these processes and account for their wide variability among healthy individuals, with 
obvious implications for patient evaluation and management. 
 
 
Ta
bl
e 
3.
1.
  C
hr
om
os
om
e 
lo
ca
tio
n,
 L
O
D
 s
co
re
, c
on
fid
en
ce
 in
te
rv
al
 a
nd
 g
en
et
ic
 d
es
cr
ip
to
rs
 o
f c
ol
la
te
ra
l Q
TL
 
id
en
tif
ie
d 
us
in
g 
m
ul
tip
le
 Q
TL
 m
od
el
. 
72
Start (bp) Symbol Orient E Description
132362957 LOC670828 - protein similar to 40S ribosomalprotein S7 (S8)
132476076 4933440M02Rik - mRNA RIKEN cDNA 4933440M02gene
132554205 LOC100043014 - protein predicted gene 4171
132588190 Jmjd5 + best RefSeq jumonji domain containing5
132611162 Nsmce1 - best RefSeq non-SMC element 1homolog (S. cerevisiae)
132690783 EG244214 + mRNA predicted gene, EG244214
132695796 Il4ra + best RefSeq interleukin 4 receptor, alpha
132746991 Il21r + mRNA interleukin 21 receptor
132784468 Gtf3c1 - best RefSeq general transcription factorIII C 1
Table 3.2.  Candidate genes resulting from EMMA analysis of chromosome 7 QTL 
locus.
Genes in grey area have p < 2.2 X 10-5 : genes in white area have p < 4.17 X 10-4.  
Orient,  orientation of transcription
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Figure 3.1. Phenotypes of the native cerebral cortical pial collateral circulation 
in C57BL/6 (B6), BALB/c (Bc), F1 and F2 mice.  A, Mouse pial arterial circulation in 
B6 (left) and Bc (right) after clearing, dilating, and filling with yellow MicrofilTM
restricted from capillary transit.  Collaterals cross-connecting the ACA and MCA trees 
in B6 are indicated (*).  The Bc brain that is shown has no MCA-ACA collaterals.  B,
Number, diameter and "conductance" (number x diameter) of collaterals compared for 
B6, Bc and F1 mice.  Data are given as mean ± SEM, with (n) = number of mice 
studied in this and subsequent figures unless indicated otherwise.  The small n-size 
for Bc diameter and conductance reflects the large number of individuals in this strain 
with no collaterals.  C, Distributions and density curves for number per hemisphere, 
diameter, and conductance of collaterals of the F2 cohort (n=221).
75
Figure 3.2.  Genome-wide mapping of collateral traits in 221 F2 mice.  A, LOD 
profiling using the single QTL model.  Locations of genotyping SNPs are shown as 
ticks on the abscissa.  95% confidence level (dashed line) was estimated using 1000 
permutations.  Inset, higher resolution genetic map of the peak on chromosome 7.  
The location of the marker nearest the peak is indicated (triangle).  B, LOD profiling 
using the multiple QTL model.  Significant QTLs were found on chromosomes 1, 3, 7, 
and 8 for number (black line), on chromosome 7 for diameter (dashed line), and on 
chromosomes 1 and 7 for conductance (dot-dash line).  Inset, schematic of the 
multiple QTL model for collateral number having the highest LOD.  The solid line 
denotes interaction between the QTLs on chromosomes 1 and 3 (LOD score 7).
76
Figure 3.3.  Influence of identified QTL on collateral traits.  A, Phenotypic effects 
of the chromosome 7 QTL.  Collateral number, diameter and conductance of parental, 
F1 and F2 mice grouped according to genotype at marker rs13479513 (see Fig. 3.1 
inset).  F2-B6/B6 mice and F2-B6/Bc mice are similar to parental B6 and F1 mice, 
resp., in all 3 traits.  F2-Bc/Bc mice are similar to Bc in diameter (middle panel).  
These suggest that the chromosome 7 QTL accounts for the major difference in 
collateral number between B6 and Bc.  However, F2-Bc/Bc mice are significantly 
different from Bc in collateral number and conductance, suggesting that additional loci 
must act with the chromosome 7 QTL to cause the very low collateral number in Bc
mice.  B, Phenotypic effects of the QTL identified by multiple QTL mapping.  For 
each trait and QTL, F2 mice were grouped by genotype at the imputed peak SNP 
(see Supplemental Methods (3)) and the average for each group plotted vs. genotype 
(see text (3)).
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Figure 3.4.  Chromosome substitution strains confirm a major effect of 
chromosome 7.  A-C, Collateral extent traits in B6, Bc, A/J, CSS7 and CSS17 mice. 
A/J and Bc are similarly different from B6 in number and diameter (p<0.001; confirms 
Zhang et al. (12)) and in conductance.  CSS7 mice (chromosome 7 in B6 replaced by 
chromosome 7 from A/J) are not different from A/J in number but are significantly 
different (p<0.003) from A/J in diameter and “conductance”.  Nonetheless, the 
replacement transfers most of the B6-A/J difference in each trait.  In CSS17, intended 
as a negative control for validation of the CSS7 approach, collateral number is 
unchanged from B6 but diameter is modestly reduced.  D, Fractions of the cerebral 
cortex area (territories) supplied by the ACA, MCA, and PCA.  B6 and Bc have identical 
territories (confirms Zhang et al. (12)), while in A/J the MCA is slightly larger and the 
PCA correspondingly smaller than in B6.  This difference is not transferred to CSS7, 
confirming the dissociation of collateral and cerebral artery tree territory phenotypes 
among inbred mouse strains (12).
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Figure 3.5.  Highly significant region within Canq1 identified by association 
mapping for native collateral number.  The EMMA algorithm (79) was applied to 
collateral trait values in the 134 individuals of the 15 strain data of Zhang et al. (12) 
and the 41,000 high quality imputed SNPs under the Canq1 peak (127 to 143 Mb; cM 
shown in the inset).  A highly significant group of 18 SNPs (p=2.2E-5, Group A) 
slightly proximal to the QTL peak resulted (inset, black triangle).  The second most 
significant group (155 SNPs, p=4.17E-4; Group B) spans a 290kb region.  The genes 
in these groups are shown in Table 3.2.  The vertical dashed lines in the insert delimit 
the 95% confidence interval of Canq1.
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Figure 3.6.  Collateral remodeling after MCA occlusion: Genome-wide mapping 
identifies a QTL on chromosome 11.  Diameter measurements made in 190 F2 
mice 6 days after right-side MCA occlusion were subjected to single QTL mapping.  
Black curve, native collateral diameter (non-occluded side); the LOD score is lower 
than in Figure 3.1 because there were fewer mice (See Supplemental Methods (3)).  
Red curve, fold increase in collateral diameter after remodeling (occluded over non-
occluded).  Blue curve, fold increase in diameter after rescanning with native 
collateral diameter as a covariate (see inset for close correlation between fold 
increase in diameter in the right hemisphere and native collateral diameter).  The 
chromosome 7 QTL for remodeling (red curve) was lost (blue curve), but a QTL for 
remodeling on chromosome 11 achieved significance (Carq1, Table 3.1; p<0.05).
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Supplemental Figure 3.1. Pial collateral number and diameter and cortical
areas for 15 inbred strains used in the EMMA analysis (reprinted from ref 12).
Variation in collateral number (per hemisphere) and diameter is unrelated to small
variations in cortex area. Number of animals is given at the base of each column.
Dashed lines on the dorsal cortex area panel delimit the 21% range of variation
among the 15 strains.
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Supplemental Figure 3.2. Gender and parental origin have no effect on
native collateral dimensions. A, Native collateral number (left panel) and
diameter of female and male F2 individuals (n = 221) were not different. B.
Average collateral number (left panel) and diameter for the 221 F2 mice
grouped according to parental origins in reciprocal crosses. In the open bar
group (CxB, CxB; F1 female, F1 male), both F1 parents resulted from mating
of a BALB/c dam (C) and a C57BL/6 sire (B). Corresponding notation holds
for the other 3 groups.
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Supplemental Figure 3.3. Native collateral traits have no relationship to body 
weight.
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Supplemental Figure 3.4. Collateral number and diameter in the F2 population
are largely distinct traits, based on the low r2 from linear regression of the two
traits.
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Collateral number
Collateral diameter
Collateral conductance
Supplemental Figure 3.5.  Genome-wide scan finds no significant interactions 
between chromosome 7 QTL and other loci known to influence collateral traits.  
Interactions were sought using likelihood ratio tests between full and additive models, 
with all identified QTL fixed in the linear model (11).  From left to right, arrows indicate 
approximate positions of Clic4, Flt1, and Vegfa, genes whose expression levels are 
positive determinants of native collateral number and diameter (114; 39; 113).  
Empirical p-value threshold for significant interaction is LOD 6.3 (1).
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P = 0.05
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Supplemental Figure 3.6. Cell-cell signaling and immune response
pathways are highly enriched in chromosome 7 QTL region. Pathway
enrichment analysis was conducted for all genes between 95% CI within Chr
7 QTL (132.3 Mb - 135.8 Mb) for all known pathways in the Ingenuity
database. P values were adjusted for multiple comparisons (Benjamini-
Hochberg; B-H p-value) and negative-logarithm-transformed.
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 A. Abstract 
Rationale.  Native (pre-existing) collaterals, which are arteriole-to-arteriole anastomoses 
that connect adjacent arterial trees and are critical in ischemic disease, vary widely in 
extent (ie, number and diameter) among inbred mouse strains.  We previously identified 
a major QTL on chromosome 7 (Canq1; LOD=29) predominantly responsible for 
variation in collateral extent in a C57BL/6 (B6) X BALB/c (Bc) F2 population.   
Objective.  Herein, we sought to identify candidate genes responsible for collateral 
variation. 
Methods and Results.  Collateral extent in the pial cerebral circulation was intermediate 
to the Bc and B6 parental strains in a CXB recombinant inbred line that splits Canq1 
between the two strains.  Phenotyping and mapping of an expanded panel of 21 
informative inbred strains narrowed the locus from the previously reported 462 kb 
interval to 1.7 kb.  Collateral extent, infarct volume after middle cerebral artery occlusion, 
bleeding time and rebleeding time did not differ in Itgal-/-, IL4-/- and IL4-receptor-α-/- mice 
relative to their respective host strains.  mRNA expression of 120 genes within the 95% 
CI of Cang1, plus 30 selected angiogenic- and proliferation/aging-related genes, in the 
pial vasculature of B6 and Bc embryos at E14.5, E16.5 and E18.5 when the collateral 
circulation forms, identified 19 differentially expressed genes within the Canq1 locus, 
plus Vegfa shown previously to impact collateral formation. 
Conclusions.  These findings narrow the Canq1 locus by additional association mapping, 
argue against involvement of Itgal and IL4-receptor-α, and identify several genes within 
the locus as high-priority candidates important in collateral formation and its wide genetic 
variation. 
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arteriogenesis 
 
 
B. Introduction 
 Occlusive vascular disease, including coronary artery disease (CAD), stroke, 
and peripheral artery disease (PAD), is a leading cause of morbidity and mortality1.  
When arterial obstruction occurs many physiological adaptive mechanisms are recruited 
to lessen the resultant ischemic tissue injury.  Among several vascular protective 
mechanisms, the contribution of the native (pre-existing) collateral circulation and 
variation in its extent (ie, number and diameter of collateral vessels) have become 
increasingly appreciated as critical determinants of the large variation in tissue injury 
among individuals1, 11, 12.   Collaterals are arteriole-to-arteriole anastomoses present in 
most healthy tissues that cross-connect occasional distal-most arterioles of adjacent 
artery trees.  They serve as endogenous bypass vessels in the face of arterial 
obstruction and provide the initial collateral network whose conductance is subsequently 
increased over days-to-weeks by enlargement/remodeling of the native collaterals 
(arteriogenesis).  Recent findings suggest that differences in extent are major 
determinants, rather than collateral remodeling, in the severity of tissue injury after 
arterial occlusion16.  
 The severity of ischemic tissue injury has long been known to vary widely 
among species and individuals.  Findings suggest that variation in injury may largely 
depend on variation in the extent of native collateral circulation.  Meier et al. found that 
coronary collateral conductance measured by coronary flow index (CFIp) varied by 
approximately 10-fold in 106 individuals without coronary artery or other heart diseases24.  
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They also followed 739 patients with chronic stable coronary artery disease over a 10-
year period, and found that CFIp is a good predictor of 10-year survival rate, with good 
collateral conductance associated with a 75 percent reduction in mortality.  In the 
cerebral circulation, Bang et al., using dynamic angiography, found evidence for a similar 
wide variability in native collateral conductance in patients with acute obstruction of the 
middle cerebral artery (MCA)27.  In mice where direct measurement of collateral density 
and diameter can be obtained, native collaterals evidenced large differences in both 
parameters in multiple tissues in adult C57BL/6 (B6) and BALB/c (Bc) strains16.  
Chalothorn et al. further found, using the cerebral pial collateral circulation as a model, 
that collaterals begin forming at ~ embryonic day 14.5 (E14.5), with collateral density 
peaking at ~ embryonic day 18.5 (E18.5) in both B6 and Bc38.  After E18.5, both strains 
evidence similar amounts of collateral pruning and maturation after birth, yielding by P21 
the collateral number and diameter present in the adult.  Thus, differences in extent of 
the collateral circulation, secondary to natural differences in genetic background, are 
primarily determined during collateral formation in the embryo.   
 We recently reported that collateral extent varied widely among 15 inbred 
mouse strains12.  Moreover, the same strains had an equally wide variation in infarct 
volume measured 24 hours after MCA occlusion that was tightly and inversely correlated 
with collateral number and diameter.  These findings establish a major role for genetic 
variation in the extent of the collateral circulation in determining variation in severity of 
ischemic tissue injury.   
 Previously, we performed a genome-wide linkage analysis in an F2 cross 
between B6 and Bc strains using collateral number, diameter and conductance—the 
product of number and diameter—as quantitative traits3.  We identified a major QTL on 
Chr 7 (Canq1) linked to all three traits.  This locus accounts for 37% of the variation in 
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collateral number (LOD = 29) in a B6 X Bc F2 population; three other loci and one 
interaction were responsible for an additional 35% of the variation.  Importantly, this 
major QTL on Chr 7 is at the same locus as a previously reported QTL linked to hindlimb 
ischemia and cerebral infarct volume17, 18.  Moreover, our findings identify the 
physiological substrate—variation in collateral extent—underlying this previously 
reported locus16.  We also used the efficient mixed model association mapping (EMMA) 
algorithm together with high-density SNPs for 15 inbred strains to narrow the Chr 7 QTL 
to a 172 kb region containing 2candidate genes (the “EMMA region”)3.   
 Given the physio- and pathophysiological significance of this locus, it is 
important to explore the underlying candidate genes for involvement in regulating 
collateral formation.  Identification of the alleles responsible for individual variation in 
collateral extent could help define the signaling pathways controlling collateral formation, 
permit stratification of patients, and aid the development of collaterogenic therapies1.  
Therefore, the goals of the present study were to further refine the EMMA region and to 
identify candidate genes underlying the Chr 7 QTL.  To this end, we phenotyped 
collateral extent in additional inbred strains sharing common SNP patterns, measured 
collateral extent in mice genetically deficient for several candidate genes, and 
determined mRNA levels within the pial circulation in mouse embryos during the period 
of collateral formation. 
  
 
C. Materials and Methods 
Animals 
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 Mouse strains:  LP/J, NON/ShiLtJ (NON), LEWES/EiJ, 129X1/SvJ (129X1), 
CAST/EiJ, C57BL/6J (B6), BALB/cByJ (Bc), Itgal-/- (B6 background), IL4-/- (B6 
background),  IL4Ra-/- (Bc background) and CXB11 recombinant inbred strain (RIL 
derived from Bc and B6 progenitors) at ~10 weeks of age were obtained from Jackson 
Laboratories.  PWD at ~10 weeks age were obtained from UNC-CH. 
 
Phenotyping 
 Mice were phenotyped for collateral number and diameter as described 
previously3, 12.  Briefly, the circulation was cleared and the pial circulation exposed.  
Arterial vessels were then maximally dilating, filled with a casting agent and fixed with 
paraformaldehyde.  Collaterals connecting the anterior cerebral (ACA) and middle 
cerebral (MCA) artery trees in both hemispheres were measured for number and lumen 
diameter from digitized images (Leica MZ16FA, Bannockburn, IL).  Cortical territories 
supplied by the MCA, ACA and PCA trees were determined morphometrically.   
 
Bleeding and re-bleeding assays 
 Bleeding and re-bleeding assays were conducted as previously described130.  
Under 1.2% isoflurane anesthesia, the tail was pre-warmed for 5 min in 50 mL of 37°C 
saline.  A 5 mm tip of the tail was quickly amputated with a fresh sterile #11 scalpel, and 
the tail was immediately returned to the saline.  The vertical distance between bleeding 
point and mouse body was 10 cm.  Bleeding time was measured as the time between 
start and cessation of bleeding.  Re-bleeding time was measured as the time between 
cessation and the start of the second bleeding. 
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Middle cerebral artery occlusion (MCAO) and measurement of infarct volume 
 As detailed previously12, the MCA was occluded at a midpoint between the 
zygomatic and temporal bones.  Twenty-four hours later, the brain was removed, sliced 
into 1-mm coronal sections and sections were stained with 2% triphenyltetrazolium 
chloride (TTC).  Infarct volumes were calculated as the sum of the cerebral cortical 
volume devoid of TTC in each section, and expressed as a percent of total cerebral 
cortex volume34. 
 
mRNA quantification 
 B6 and Bc breeding pairs were paired at 10-12 weeks of age.  The presence of 
a vaginal plug the morning after pairing was designated as 0.5 days post-coitus (E0.5).  
Mice were collected at E14.5, E16.5, and E18.5.  Embryos were removed under deep 
anesthesia (ketamine+xylazine, 100+15 mg/kg) and staged according to crown-to-rump 
length.  Brains were quickly removed from embryos into RNAlater® (Sigma-Aldrich Corp., 
St. Louis, MO) and stored at -20ºC.  At least 24 hours later, the embryonic pial 
circulation was peeled from the underlying dorsal cerebral cortex of both hemisphere 
using fine forceps under a stereomicroscope and stored in RNAlater® at -20ºC; pia from 
8-10 embryos of each strain were pooled for each RNA sample (> 2 litters per pool) at 
three embryonic time-points (E) days:  E14.5, E16.5 and E18.5.  At each time-point for 
each strain, three pooled RNA sample were prepared (18 total samples).  Samples were 
thawed in RNAlater and homogenized (TH, Omni International, Marietta, GA) in Trizol 
Reagent (Invitrogen, Carlsbad, CA).  The aqueous phase was extracted and RNA 
precipitated with ethanol.  Total RNA was purified using the RNeasy Micro Kit according 
to the manufacturer (Qiagen, Valencia, CA).  RNA concentration and quality were 
determined by NanoDrop 1000 (Thermo Scientific, Wilmington, DE) and by Bioanalyzer 
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2100 (Agilent, Foster City, CA), respectively.  mRNA measurement was conducted by 
the genomics facility at UNC-CH using NanoString customized probes (NanoString, 
Seattle, WA)131, 132.       
 
Association mapping 
 As detailed previously3, 79, the EMMA algorithm was applied in R to the 
collateral number trait on 21 inbred strains, representing 6 new strains (8-10 individuals 
each) in addition to data obtained for 15 strains previously12.  Briefly, the kinship matrix 
among 21 inbred strains was calculated using the dense SNP set within the Canq1 
region, where kinship matrix represents the pair-wise relatedness among 21 strains80.  
To account for the relatedness among the strains, the kinship matrix was modeled as 
random effects.  Each SNP within Canq1 was modeled as a fixed effect.  After the mixed 
model was fitted, an F test was conducted and p value obtained at each SNP location79.   
 
Statistical analysis 
 ANOVA, Student’s t-tests and Bonferroni correction on pre-planned multiple 
comparisons were conducted where appropriate.  Statistical treatment of association 
mapping data was as described previously3. 
 
 
D. Results 
Collateral number in CXB11.HiAJ RIL verifies chromosome 7 QTL, Canq1 
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 The CXB recombinant inbred lines (RILs) originated from Bc and B6 parentals 
105.  Among them, CXB11.HiAJ (CXB11) is particularly relevant.  Given the unique 
mosaic genetic structure for each RIL created by cross-over, we hypothesized that if 
Canq1 in general, and if the EMMA region in particular, are predominant determinants of 
collateral extent, an RIL that inherits these loci from either B6 (abundant large diameter 
collaterals) or Bc (sparse small diameter collaterals) will exhibit a collateral extent 
dominated by the parental phenotype3.  CXB11 splits the Canq1 locus such that both the 
EMMA region and the proximal half of the locus are obtained from B6 (Figure 4.1A).       
 CXB11 averaged 5.2 collaterals per hemisphere, compared to 9.2 in B6 and 
0.2 in Bc.  Lumen diameter averaged 21um for CXB11, close to that of B6 (23um) and 
different from Bc (13um) (Figure 4.1B).  These results confirm our previous finding3  that 
Canq1 harbors one or more variants governing collateral extent, probably in the proximal 
half.  However, it is not possible to differentiate between an effect of mosaicism 
elsewhere in the CXB11 genome versus a contribution of a variant (s) within Canq1 but 
distal to Itgal to explain the intermediate phenotype for collateral number. To differentiate 
these two confounding effects, a congenic strain which contains only half of Canq1 may 
be very useful in the future.  Because varying amounts of cortical territory supplied by 
each of the cerebral arteries (MCA, ACA, and PCA) (ie, “tree size”) could, in principle, be 
determinants of pial collateral extent12, we measured the percentage of territory 
supplied by each tree.  These data (Figure 4.1c) fall within the range of tree size data 
previously shown to have no correlation with collateral extent and so do not explain the 
CXB11 results.12. 
 
Additional inbred strains strengthen and refine the EMMA region 
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 EMMA mapping is more efficient computationally and better accounts for 
population structure embedded in inbred strains, compared to traditional association 
mapping algorithms79.  We previously applied this algorithm to 15 inbred strains and 
obtained a most significant 172kb region (p = 2.2 X 10-5) and a second-most significant 
region (290kb, p = 4.2 X 10-4)3.  To facilitate analysis, we generated a heatmap of the 
imputed SNPs within the 172 kb region for 74 inbred strains (Figure 4.2).  The lowest 15 
strains on the y-axis were those used previously.  The lowest 5 of these have 
significantly fewer collaterals than B6.  Among these 15 strains, 9 out of 10 with high 
collateral number have a blue DNA haplotype-like block, whereas all 5 strains with low 
collateral number have a largely green block, i.e. mostly green, not much blue.  An 
exception is SJL/J, which has a green block but averages 10 pial collaterals per 
hemisphere.  To verify the robustness of the EMMA region for variation in collateral 
number in mice, we chose 6 more informative inbred strains from the 74 lines:  3 strains 
with haplotype structures within the EMMA region predicting high collateral number (blue; 
129X1, LP, NON), and 3 strains with haplotypes predicting low collateral number (green; 
CAST/Ei, PWD, LEWES/Ei).  Average collateral numbers per hemisphere for 129X1, LP 
and NON were 10.4, 6.0, and 8.8, whereas CAST/Ei, PWD, LEWES/Ei were 8.6, 10.1 
and 3.0 (Figure 4.3, Supplemental figure 4.1).  Thus, collateral numbers in 4/6 strains 
fit the phenotypes predicted by their haplotype structures.  The two strains that do not 
are wild-derived strains, which have more complex haplotype structures.     
 An important consideration is whether the EMMA peak shifts position or the 
previous significant SNPs change their p values after EMMA mapping of the above 
additional 6 strains added to the previous 15 stains.  The results show that the most 
significant region did not change position, that this previous EMMA peak region was 
narrowed from 172kb to 2kb, and that the new peak evidenced increased significance (p 
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= 9 X 10-6, originally p = 2.2 X 10-5) (Figure 4.4).  Of note, we also eliminated possible 
errors from imputations by replacing 2,859 imputed SNPs with new genotyped data 
downloaded from http://compgen.unc.edu/wp/.   
 The kinship matrix used to account for population structure can vary with use of 
different SNP datasets80.  Furthermore, we previously didn’t allow the missing genotypes 
with consideration of the decrease of statistical power3.  We thus examined the effects of 
several parameters on our new EMMA mapping results by doing or not doing the 
following:  allowing missing genotypes in less than 3 strains; using only informative 
SNPs; excluding wild-derived inbred strains.  Irrespective of these mapping parameters, 
4 SNPs always had the most significant p values (rs32978185, rs32978627, rs32973294, 
and rs32973297; 132.502-132.504 Mb; Supplemental figures 4.2-4.6).  However, there 
is nothing annotated in this region.        
 
Collateral extent, hemostasis and infarct volume in IL4Ra-/-, IL4-/- and Itgal-/- do not 
support these genes as candidates for Canq1 
 We previously identified IL4Ra (interleukin 4 receptor alpha chain) in the 
second-most significant region defined by EMMA mapping3.  Homodimers or 
heterodimers of IL4Ra and Yc function as receptors for IL4 and IL13 cytokines133-135.  IL4 
is a pleiotropic cytokine that mediates a Th2 inflammatory response in addition to 
inducing production of IgE in B cells.  Evidence indicates that IL-4 may promote an 
inflammatory vascular endothelial phenotype including up-regulation of VCAM-1, MCP-1, 
and vascular endothelial growth factor (VEGF)136, 137.  Yamaji-Kegan et al. recently 
demonstrated that hypoxia-induced VEGF is significantly diminished in IL4-/- mice (B6 
background).  Furthermore, hypoxia-induced pulmonary angiogenesis and proliferation 
in airways and pulmonary artery were suppressed in IL4 deficient mice137.  In addition, 
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VEGF is an important determinant of collateral formation in the embryo34.  Despite these 
rationales, IL4-/- mice had no deficit in collateral extent (9.5 collaterals/hemisphere, 21um 
diameter) compared to B6 (9.3 and 23um, respectively) (Figure 4.5).  Bc is well known 
to mount a Th2-dominant response, compared with B6 which is Th1-dominant135, 138.  
Accordingly, T cells from Bc produce greater amounts of IL4, IL4Ra, and IL13.  We thus 
examined IL4Ra-/- (only available on Bc background).  Collateral extent in IL4Ra 
deficient mice was similar to Bc (0.2 collaterals, 17um diameter versus Bc, 0.2 and 13um, 
respectively).  The above results from two knockout strains do not support involvement 
of IL4Ra in variation of collateral extent. 
Itgal is located at 134Mb near the peak of Canq1 and encodes an integrin alpha 
L chain.  This polypeptide binds an integrin beta-2 chain to form lymphocyte function-
associated antigen-1 (LFA-1), which is expressed on the surface of leukocytes139-141.  
LFA-1 plays a central role in leukocyte trafficking through interactions with its 
intercellular adhesion molecule (ICAM) ligands expressed on endothelial cells.  Several 
signaling pathways are activated upon binding of ICAM by LFA-1 to effect infiltration of 
lymphocytes.  Many lines of evidence suggest that Itgal is involved in immune response, 
inflammation and ischemic injury140.  Keum and Marchuk identified Itgal as a candidate 
gene for infarct volume measured 24 hours after MCAO in a B6 X Bc F2 population, 
using genome wide linkage analysis and interval-specific SNP haplotype association 
mapping18.   Furthermore, Arumugam et al., using a 1 hour transient MCAO model, 
found that LFA-1-/- mice had smaller infarct volumes measured 24 hours after 
reperfusion, compared to B6142.  Although, many factors contribute to the severity of 
ischemic injury besides collateral extent, including types of ischemic models, the no-
reflow effect of leukocyte plugging, and hemostasis143-147,  these findings led us to 
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examine whether Itgal modulates collateral abundance.  However, Itgal-/- and B6 controls 
had similar collateral extent (Figure 4.5).   
We also determined infarct volume 24h after permanent MCAO, since collateral 
extent is the major determinant of strain-dependent variation in this model of stroke12 
and the above mentioned previous studies suggest involvement of Itgal18, 142.  Consistent 
with our finding of no difference in collateral extent, infarct volume was not different in 
Itgal-/- mice, compared to B6 controls and as referenced to Bc that exhibit larger 
infarctions (Figure 4.6).  Neither was it affected in IL4-/- mice (B6 background), in 
agreement with collateral extent (Figure 4.5).  These findings do not support Itgal (or IL4 
or IL4ra) as a candidate gene for Canq13 or the previously reported Civq118.  
Given that MCA tree size is also a determinant of infarct volume after 
permanent12 or transient MCAO, we also examined MCA tree size in these strains.  Tree 
size was smaller in Itgal-/- mice (Figure 4.5), which may explain the smaller infarct 
volume observed after transient MCAO in Itgal-/- mice142.  We did not observe a 
difference with permanent MCAO (Figure 4.6), which may result from an effect on re-
bleeding time (see below).   
Leukocyte/platelet adhesion and hemostasis have complex effects on infarct 
volume, especially secondary to transient occlusion, through effects on 
thrombosis/thrombolysis, hemostasis and inflammatory mechanisms148.  Moreover, 
thrombosis and thrombolysis have been reported to vary widely dependent on genetic 
backgrounds130.  Because these mechanisms could be affected in Itgal-/- mice, and 
possibly also in IL4-/- mice, we measured bleeding and re-bleeding time to assay 
thrombosis and thrombolysis, respectively.  No differences were observed among 
knockouts, B6 controls or the Bc strain (Figure 4.6), with the exception of shorter time to 
re-bleeding in Itgal-/- mice.  Depending on models and severity of stroke, increased 
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thrombolysis can either reduce no-reflow and lessen infarct volume, or increase 
petechial hemorrhage and increase infarct volume148.   
 
Expression of genes within Canq1  
 The highly significant SNPs within the EMMA peak (Figure 4.4), together with 
the strength of the Canq1 locus (LOD 29, heritability 37%)3, strongly suggests that a 
gene(s) or genetic element(s) within the EMMA region or the much wider Canq1 locus 
may be polymorphic, resulting in differences in expression of the given or an adjacent 
gene(s) that governs variation in collateral formation.  To explore this possibility, we 
measured mRNA levels of genes within the 95% CI of Canq1 in the B6 and Bc parental 
strains of the F2 population from which the locus was mapped.  In the pial circulation 
collateral formation begins with the appearance of a plexus of collateral vessels that 
starts to form between the crowns of the cerebral artery trees and between branches 
within the trees (intra-tree anastomoses, ITAs) at E14.5 and reaches its peak density by 
E18.5 in both B6 and Bc38.  60-70% fewer collaterals and ITAs form in the Bc strain.  
Between E18.5 and postnatal day 21, an equal number of collaterals and virtually all of 
the ITAs are pruned away in both strains, yielding the number and diameter of collaterals 
present in the adult (eg, Figure 4.5)16, 38.  We thus examined expression in both strains at 
E14.5, E16.5 and E18.5 for three groups of genes:  genes with SNP variation between 
B6 and Bc strains in coding or regulatory (ie, the 5’ and 3’ 2kb non-coding) regions within 
the 95% CI of Canq1 including the 172 kb EMMA region (132.356 - 132.528 Mb); 
selected angiogenic-related genes, and selected genes related to proliferation and aging.  
Among 150 genes, 19 genes located within the 95% CI of Canq1 have adjusted p values 
less than 0.05 for a difference between strains (Bonferroni correction, Table 4.1, Figure 
4.7).  Nine of these are more than 2-fold higher in Bc than in B6 at all time-points, while 
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one gene, Pycard, is at least 60% higher in B6.  Nsmce1 (132.6 Mb), located in the 
second-most significant EMMA region (132.53 - 132.82 Mb), has three splicing isoforms, 
with two expressing 2-to-7-fold higher levels in Bc (Table 4.1, Supplemental table 4.1).  
On the other hand, expression of 6 genes significantly changed over the 3 time-points, 
including two angiogenic-related genes and four genes in Canq1.  
 
 
E. Discussion 
 In present study we sought to confirm Canq1 and the EMMA region reported 
previously3.  The collateral phenotype of CXB CXB11, in which the proximal half of 
Canq1 derives from B6, was intermediate for collateral number between B6 and Bc, and 
not different from B6 for collateral diameter.  With Canq1 alone accounting for a large 
fraction of heritable variation in collateral extent3, this result confirms our previous 
findings that Canq1 harbors one or several important variants governing collateral 
extent.  Our previous linkage analysis showed that Canq1 alone accounts for 37% of the 
phenotypic variation, with three other loci plus an interaction explaining 35% additional 
variation.  However, because of the small effects (LOD < 6) and broad ranges (> 5Mb) of 
these other QTL on Chr 1, 3, and 8, CXB11 has mosaic structures within these loci.  
Thus, it is impossible to verify whether the EMMA region harbors the causal variation of 
Canq1 by phenotyping CXB11 alone.  To verify and possibly narrow down this region, 
we phenotyped 6 more inbred strains chosen according to their haplotype structures 
within the region.  Four of 6 inbred strains had the predicted collateral extent.  We then 
subjected this panel of now 21 strains to EMMA mapping, narrowing the region 
considerably.  Together, these three approaches verify, strengthen and better define the 
importance of Canq1 and the EMMA region within it.   
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 By examining mRNA expression of candidate genes within both regions, we 
were able to identify for future study a number of genes as high-priority candidates 
potentially regulating collateral formation.  As a first step in this effort, we examined 
knock-out mice for two genes within Canq1 (Itgal, IL4Ra) and one acting on a gene 
within the locus (IL4) that may be involved in 149, and found no supportive evidence.  
While conclusions based on gene knockout mice have limitations (eg, compensations 
from global deletion, lack of ability to test for variants producing gain-of-function or 
increased expression), this conclusion is strengthened by the absence of a significant 
difference in expression of Itgal and IL4ra between B6 and BALB/c during the time when 
collateral formation is occurring (adjusted p >0.76).   
   Two of the 6 strains chosen, Cast/Ei and PWD, for expanded EMMA mapping 
were outlier (Figure 4.3).  The unique haplotype structures of these wild-derived strains 
have discouraged their use in previous mapping studies150, 151, a finding which our 
results confirm.  However, LEWES—also a wild-derived strain—fit the predicted 
collateral number.  Several studies have utilized dense SNPs from the recently re-
sequenced 15 strains (NIEHS and Perlegen) to infer ancestral haplotype origins for the 
classical inbred strains151, 152.  By using Cast/Ei, PWD, and WSB as references for Mus 
Musculus subspecies castaneus, musculus, and domesticus, together with the hidden 
Markov Model algorithm, Frazer et al. found that the classical 11 inbred strains shared 
68% haplotype origins with domesticus (WSB), 6% with musculus (PWD), and 3% with 
castaneus (Cast/Ei)152.  In another study, Yang et al. found that wild-derived strains, 
which are presumed to represent different mouse subspecies, show substantial 
intersubspecific introgression151.  Using the 72% of the autosomal and X-chromosomal 
100 kb genomic intervals for which the ancestry of the reference strains is unambiguous, 
they estimated that the classical 11 inbred strains inherited, on average, 92% of their 
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genomes from Mus domesticus origin, 3-12% from musculus origin, 1-2% from 
castaneus origin.  In a recent study, Kirby et al. densely genotyped 121k SNPs for 94 
inbred strains150.  Based on SNP analysis, LEWES has close ancestral origins with the 
WSB strain.  We thus postulate that because Cast/Ei and PWD share minimal ancestral 
haplotype origins with the classical inbred strains, these two wild-derived strains were 
outlier in our study, while LEWES, which shares major ancestry origin with the classical 
inbred strains, evidenced the predicted collateral number (Figure 4.3).  However, 
regardless of whether the three wild-derived strains were included or excluded in EMMA 
mapping, the same significant region was obtained (132.502 to 132.504 Mb) with 
invariant p values (<10-6) (Supplemental Figures 4.2-4.6).  Moreover, the diverse genetic 
background used in our EMMA mapping was corrected by applying the kinship matrix.  
For example, the average identical by descent (IBD) is 0.45 between Cast/Ei and the 
other 20 stains, whereas IBD averages 0.82 between B6 and the other 20 strains.  
 The most significant region (p < 9 X 10-6, 132.502 to 132.504Mb) and its 
adjacent extended region (p < 3.8 X 10-4, 132.495 to 132.513Mb) identified by EMMA 
mapping with 21 inbred strains were examined for mRNA annotation.  No annotation 
was found in this region (http://uswest.ensembl.org/Mus_musculus/Location 
/View?r=7:132495610-132513000).  The examination in UCSC genome browser 
database confirmed this result.  The gene 4933440M02RIK is located 2.3 kb at the 
upstream of this region while Jmjd5 positions 6.5 kb downstream.  MicroRNA and 
ncRNA were also absent in this region (http://www.ncrna.org/).  We further examined 
this extended region for transcription binding factors using Transcription Element Search 
System (TESS) (http://www.cbil.upenn.edu/cgi-bin/tess/tess?RQ=WELCOME)153, 154.  No 
mammalian transcription factor binding sites were identified. 
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 SJL, which has high pial collateral density yet possesses a haplotype structure 
similar to that of SWR, is also outlier (Figure 4.2 and Figure 4.3).  Among approximately 
one thousand SNPs within the most significant EMMA region, 400 SNPs imputed with 
high confidence (>0.9) are identical between SWR and SJL, and the genotypes of the 
remaining SNPs imputed with lower confidence are also the same.  If no variation exists 
within the EMMA region between SWR and SJL, what genetic components regulate the 
variation in native collateral extent between these two strains?  Effort to identify the 
novel genetic component(s) using an SWR X SJL F2 cross is currently under way. 
     In conclusion, the present results significantly reduce the priority of several 
candidate genes previously identified underlying the Chr 7 QTL3, 17, 18.  On the other 
hand, locus-wide expression analysis suggests a number of interesting new candidates, 
eg, Nsmce1.  Use of additional inbred strains has verified and narrowed down the 
previous EMMA region.  Although this region (132.502 to 132.504 Mb) contains no 
genes, variation within this region is highly associated with variation in native collateral 
extent.  Thus, complete sequencing of this region may lead to clues regarding this 
important source of collateral variation.  Additional insight may be obtained if more 
inbred mouse strains with predicted low pial collateral density can be identified as new 
information on ancestral haplotype sharing patterns becomes available. 
  
Gene* 
number Name Description
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
111 Pycard PYD and CARD domain containing Gene II 135135617 -2.29 -1.67 -1.79 0.0003 0.0595
124 Inpp5f inositol polyphosphate-5-phosphatase F II 135754842 1.90 1.69 2.30 0.0036 1.0000
47 Tbx6 T-box 6 II 133924997 2.38 2.09 2.89 0.0055 1.0000
16 D430042O09Rik-204 RIKEN cDNA D430042O09 gene II 132851390 3.94 2.61 3.65 0.0073 1.0000
9 Nsmce1-003 non-SMC element 1 homolog I 132611154 5.54 3.58 7.09 0.0084 1.0000
150 telomerase NM_009354.1 IV 73764438 3.99 2.14 3.87 0.0085 1.0000
8 Nsmce1-002 non-SMC element 1 homolog I 132611154 2.52 2.05 3.57 0.0122 1.0000
26 Nfatc2ip
nuclear factor calcineurin-dependent 2 
interacting protein II 133526368 1.68 1.69 2.05 0.0125 1.0000
55 Taok2 TAO kinase 2 II 134009192 1.65 1.38 1.97 0.0143 1.0000
110 B230325K18Rik RIKEN cDNA B230325K18 II 135126593 9.69 4.68 7.75 0.0165 1.0000
91 1700120K04Rik RIKEN cDNA 1700120K04 gene II 134747592 3.37 1.99 2.35 0.0177 1.0000
80 9130019O22Rik RIKEN cDNA E430018J23 gene II 134525774 3.63 2.28 3.78 0.0190 1.0000
87 1700008J07Rik non-coding RNA II 134655683 2.64 1.87 3.05 0.0202 1.0000
120 BC017158 UPF0420 protein C16orf58 homolog II 135414893 1.56 1.43 1.67 0.0226 1.0000
140 Vegfa188 vascular endothelial growth factor A III 46153942 1.88 1.45 2.05 0.0236 1.0000
88 Phkg2 phosphorylase kinase, gamma 2 II 134716854 1.70 1.34 2.19 0.0250 1.0000
19 D430042O09Rik-209 RIKEN cDNA D430042O09 gene II 132851390 2.04 2.09 5.63 0.0284 1.0000
41 Giyd2 GIY-YIG domain containing 2 II 133832982 1.57 1.63 2.40 0.0291 1.0000
54 Ino80e INO80 complex subunit E II 133995094 4.64 2.71 3.79 0.0343 1.0000
127 Dock1 dedicator of cytokinesis 1 II 141862370 1.87 2.15 2.47 0.0384 1.0000
Table 4.1.  Genes having differential expression either between strains or among different embryonic days 
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Gene* 
number Name Description
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
122 Tial1
Tia1 cytotoxic granule-associated RNA 
binding protein-like 1 II 135583291 2.02 1.54 2.12 0.0418 1.0000
109 Fus malignant liposarcoma gene II 135110971 1.47 1.49 1.72 0.0428 0.6911
40 Sult1a1
sulfotransferase family 1A, phenol-
preferring, member 1 II 133816379 -2.29 1.01 1.76 1.0000 0.0026
129 Angiopoietin 2 angiopoietin 2 III 18690263 -1.15 1.14 1.61 1.0000 0.0077
139 TGFb growth factor beta binding protein 1 III 75404869 1.30 1.18 1.32 0.1245 0.0087
37 Nupr1 nuclear protein 1 II 133766763 -1.72 1.21 1.70 1.0000 0.0096
65 Qprt-001 quinolinate phosphoribosyltransferase II 134250628 -1.55 -1.19 1.10 1.0000 0.0377
20 AC150648.2 GSG1-like II 133024217 -1.59 -1.28 -1.27 1.0000 0.0448
Expression assay by Nanostring nCounter.  3 RNA samples of pia at each time point for each strain, with each sample composing 
of ≥ 8 embryos from ≥  2 litters.  
* Gene number same as in Figure 4.7 and Supplemental Table 4.1.
†  II, gene in 95% CI of Chr 7 QTL;  I, genes within the EMMA region; IV, proliferation/aging-related genes;  III, angiogentic-related      
genes.  
‡  Fold change for BALB/c vs B6 if positive and B6 vs BALB/c if negative. 
§ Bonferroni-adjusted p values from two-way ANOVA for strain and embryonic day.
Table 4.1 (continued) 
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Gene* 
number Name Accession number
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
1 EG545999 XM_620562.3 I 132218849 -1.02 1.3 1.33 1 1
2 LOC670828 LOC670828.1 I 132362963 1.44 1.12 1.84 1 1
3 4930533L02Rik AK015957.1 I 132461873 -1.33 1.13 1.41 1 1
4 4933440M02Rik XR_035453.1 I 132473157 1.48 -1.16 1.25 1 1
5 Jmjd5-001 ENSMUST00000033010.1 I 132588190 1.19 1.35 1.3 1 1
6 Jmjd5-002 ENSMUST00000135129.1 I 132588190 -1.62 1.07 1.31 1 1
7 Nsmce1-001 ENSMUST00000033006.1 I 132611154 1.36 1.36 1.66 0.0852 1
8 Nsmce1-002 ENSMUST00000138616.1 I 132611154 2.52 2.05 3.57 0.0122 1
9 Nsmce1-003 ENSMUST00000149289.1 I 132611154 5.54 3.58 7.09 0.0084 1
10 EG244214 XR_002216.2 I 132690783 1.26 1.01 1.69 1 1
11 Il4ra-201 ENSMUST00000033004.1 I 132695785 -1.92 -1.93 -1.02 0.7669 1
12 Il21r-201 ENSMUST00000033000.1 I 132746983 -1.19 -1.1 -1.06 1 1
13 Il21r-202 ENSMUST00000084605.1 I 132746983 1.07 1.17 -1.19 1 1
14 Gtf3c1-201 ENSMUST00000055506.1 I 132784469 1.25 1.19 1.47 0.1134 0.1431
15 Gtf3c1-202 ENSMUST00000106423.1 I 132784469 1.04 -1.09 1.09 1 1
16 D430042O09Rik-204 ENSMUST00000122337.1 II 132851390 3.94 2.61 3.65 0.0073 1
17 D430042O09Rik-205 ENSMUST00000124223.1 II 132851390 1.13 -1.06 -1.14 1 1
18 D430042O09Rik-206 ENSMUST00000132204.1 II 132851390 1.24 -1.04 1.11 1 1
19 D430042O09Rik-209 ENSMUST00000155059.1 II 132851390 2.04 2.09 5.63 0.0284 1
20 AC150648.2 NM_001101488.1 II 133024217 -1.59 -1.28 -1.27 1 0.0448
Supplemental Table 4.1.  Expression for all genes as assayed by Nanostring nCounter
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Gene* 
number Name Accession number
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
21 Xpo6 NM_028816.2 II 133245237 1.49 1.25 1.63 0.0861 1
22 Sbk1 NM_145587.2 II 133416133 1.08 -1.11 -1.09 1 1
23 AC135809.1 XM_001479519.1 II 133442948 1.09 1.11 1.55 1 1
24 Lat NM_010689.2 II 133507346 -1.34 1.34 1.09 1 1
25 Spns1 NM_023712.2 II 133513574 -1.25 1.11 1.23 1 1
26 Nfatc2ip NM_010900.2 II 133526368 1.68 1.69 2.05 0.0125 1
27 Cd19 NM_009844.2 II 133552519 1.38 1.63 1.51 1 0.9776
28 Rabep2 NM_030566.2 II 133572273 1.31 1.41 2.22 0.2858 1
29 Atp2a1 NM_007504.2 II 133589372 1.38 1.15 1.34 1 1
30 Sh2b1 NM_001081459.1 II 133610508 1.18 1.09 1.36 1 1
31 Tufm NM_172745.3 II 133630892 1.18 1.17 1.61 1 1
32 Atxn2l NM_183020.1 II 133635224 1.46 1.21 1.52 0.1097 1
33 Eif3c NM_146200.1 II 133690426 1.34 1.3 1.63 0.1887 1
34 Cln3 NM_001146311.1 II 133714721 1.6 1.28 2.23 0.0697 1
35 Apob48r NM_138310.1 II 133728456 -1.07 1.12 1.38 1 1
36 Il27 NM_145636.1 II 133732524 1.44 -1.15 1.17 1 1
37 Nupr1 NM_019738.1 II 133766763 -1.72 1.21 1.7 1 0.0096
38 2510046G10Rik ENSMUST00000084587.1 II 133792737 1.26 1.26 1.75 0.6995 1
39 Ccdc101 NM_029339.2 II 133792823 1.5 1.5 2.21 0.2086 1
40 Sult1a1 NM_133670.1 II 133816379 -2.29 1.01 1.76 1 0.0026
Supplemental Table 4.1 (continued) 
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Gene* 
number Name Accession number
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
41 Giyd2 NM_029420.3 II 133832982 1.57 1.63 2.4 0.0291 1
42 Bola2 NM_175103.3 II 133838915 1.35 1.26 1.75 0.4726 1
43 Coro1a NM_009898.2 II 133843287 1.15 1.05 1.42 1 0.4048
44 Mapk3 NM_011952.2 II 133903115 1.05 1.18 1.41 1 1
45 Gdpd3 NM_024228.2 II 133909928 1.74 1.35 2 0.8226 1
46 Ypel3 NM_026875.2 II 133920469 1.19 1.15 1.66 0.3037 1
47 Tbx6 NM_011538.2 II 133924997 2.38 2.09 2.89 0.0055 1
48 Ppp4c NM_019674.3 II 133929421 1.16 1.18 1.33 1 1
49 Aldoa NM_007438.3 II 133938748 1.25 1.04 1.58 1 1
50 Fam57b-201 ENSMUST00000079423.1 II 133963344 1.79 -1.08 1.55 1 1
51 Fam57b-202 ENSMUST00000098032.1 II 133963344 1.23 1.36 1.63 1 1
52 4930451I11Rik NM_183131.2 II 133973988 -1.22 -1.3 1.19 1 1
53 Doc2a NM_010069.1 II 133990930 3.7 -1.27 1.94 1 1
54 Ino80e NM_153580.1 II 133995094 4.64 2.71 3.79 0.0343 1
55 Taok2 NM_001163774.1 II 134009192 1.65 1.38 1.97 0.0143 1
56 Tmem219 NM_028389.1 II 134029685 1.48 1.39 1.99 0.1386 1
57 Kctd13 NM_172747.2 II 134072393 1.26 -1.02 1.28 1 1
58 Sez6l2 NM_144926.4 II 134085658 1.36 -1.23 1.24 1 1
59 Asphd1 NM_001039645.1 II 134089081 1.7 1.08 1.61 1 1
60 Cdipt NM_138754.3 II 134119902 1.06 1.28 1.5 1 1
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Gene* 
number Name Accession number
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
61 Mvp NM_080638.2 II 134130382 -1.26 1.13 1.21 1 1
62 2900092E17Rik NM_030240.1 II 134144996 1.71 1.43 2.42 0.1198 1
63 Kif22 NM_145588.1 II 134171246 1.37 1.45 1.71 1 1
64 AI467606 NM_178901.3 II 134234873 -1.01 1.35 1.62 1 1
65 Qprt-001 ENSMUST00000032912.1 II 134250628 -1.55 -1.19 1.1 1 0.0377
66 Qprt-002 ENSMUST00000129332.1 II 134250628 1.35 1.72 1.81 0.2412 0.1273
67 Qprt-003 ENSMUST00000142403.1 II 134250628 1.61 2.19 4.1 1 1
68 Cd2bp2 NM_027353.3 II 134337200 1.32 1.23 1.46 0.0554 1
69 Tbc1d10b NM_144522.5 II 134340979 1.01 -1.02 1.18 1 1
70 Mylpf NM_016754.5 II 134355122 1.17 1.14 1.62 1 1
71 Sept1 NM_017461.2 II 134357961 1.33 1.68 1.66 0.2131 1
72 AC133494.1 NR_030674.1 II 134376338 3.03 1.9 3.23 0.0625 1
73 Zfp553 NM_146201.1 II 134376575 1.02 1.05 1.06 1 0.8373
74 Zfp771 NM_177362.3 II 134388040 1.16 1.05 1.31 1 1
75 Dctpp1 NM_023203.1 II 134400473 1.38 1.11 1.48 1 1
76 Sephs2 NM_009266.3 II 134416075 1.14 1.12 1.27 1 1
77 Itgal-003 ENSMUST00000120857.1 II 134439774 1.82 2.09 1.76 1 1
78 Zfp768 NM_146202.1 II 134486312 1.22 -1.02 1.65 1 1
79 Zfp747 NM_175560.3 II 134516078 1.49 1.42 1.98 0.0991 1
80 9130019O22Rik NM_030226.2 II 134525774 3.63 2.28 3.78 0.019 1
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Gene* 
number Name Accession number
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
81 AC133494.2 NM_198011.1 II 134527268 1.35 1.15 1.65 0.8822 1
82 Zfp764 NM_146203.3 II 134547182 1.4 1.44 2.1 0.1708 1
83 Zfp689 NM_175163.3 II 134587266 1.31 1.44 1.9 0.2063 1
84 Prr14 NM_145589.2 II 134603125 1.26 1.12 1.64 0.7564 1
85 Fbrs NM_010183.1 II 134629170 1.22 1.14 1.46 0.2593 1
86 Srcap XM_001480403.1 II 134655516 1.33 1.15 1.53 0.255 1
87 1700008J07Rik NR_024331.1 II 134655683 2.64 1.87 3.05 0.0202 1
88 Phkg2 NM_026888.3 II 134716854 1.7 1.34 2.19 0.025 1
89 Gm166 NM_001033040.2 II 134726602 2.31 1.63 2.26 0.2001 1
90 Rnf40 NM_172281.1 II 134732281 1.18 1.25 1.42 0.1315 1
91 1700120K04Rik NR_027915.1 II 134747592 3.37 1.99 2.35 0.0177 1
92 Zfp629 NM_177226.5 II 134750545 1.24 1.08 1.62 1 1
93 Bcl7c NM_009746.2 II 134806867 -1.05 -1.01 1 1 1
94 Ctf1 NM_007795.1 II 134856258 1.53 1.1 1.54 0.2593 0.1427
95 Ctf2 NM_198858.1 II 134861620 1.32 1.05 1.15 1 1
96 Fbxl19 NM_172748.2 II 134890289 1.47 1.07 1.5 1 0.8551
97 Orai3 NM_198424.3 II 134913329 2 1.59 2.73 0.1136 1
98 Setd1a NM_178029.3 II 134920184 1.39 1.3 1.58 0.1413 1
99 Hsd3b7 NM_133943.2 II 134929122 1.06 1.27 1.53 1 0.2238
100 Stx1b NM_024414.2 II 134947414 1.93 1.03 1.76 1 1
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number Name Accession number
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
101 Stx4a NM_009294.3 II 134967808 1.34 1.41 1.88 0.7125 1
102 Zfp668 NM_146259.3 II 135008684 1.7 1.21 1.82 0.1367 1
103 Zfp646 NM_172749.4 II 135020310 1.35 1.31 1.59 0.076 1
104 BC039632 NM_001081268.1 II 135029355 1.88 1.29 2.15 1 1
105 Vkorc1 NM_178600.2 II 135029741 1.07 1.27 1.68 1 1
106 Myst1 NM_026370.1 II 135056031 1.56 1.33 2.1 0.0889 1
107 Prss8 NM_133351.2 II 135069232 -1.26 1.5 1.71 1 1
108 Prss36 NM_001081374.1 II 135076152 1.15 1.25 1.65 1 1
109 Fus NM_139149.2 II 135110971 1.47 1.49 1.72 0.0428 0.6911
110 B230325K18Rik NM_176936.2 II 135126593 9.69 4.68 7.75 0.0165 1
111 Pycard NM_023258.4 II 135135617 -2.29 -1.67 -1.79 0.0003 0.0595
112 Trim72 NM_001079932.2 II 135147503 2.19 2.07 2.27 0.7767 1
113 Itgax NM_021334.2 II 135273061 1.25 1.75 1.36 1 1
114 Itgad NM_001029872.1 II 135298292 1.65 -1.07 1.06 1 1
115 Cox6a2 NM_009943.2 II 135349128 1.05 1.18 1.76 1 1
116 9130023H24Rik NM_177001.3 II 135379920 1.21 1.39 1.74 0.6463 1
117 Armc5 NM_146205.2 II 135381630 -1.15 1.03 1.07 1 1
118 Tgfb1i1 NM_009365.2 II 135390385 5.01 4.35 5.85 0.0634 1
119 Slc5a2 NM_133254.3 II 135409171 1.14 1.29 1.5 1 1
120 BC017158 NM_145590.1 II 135414893 1.56 1.43 1.67 0.0226 1
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number Name Accession number
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
121 Rgs10 NM_026418.2 II 135517135 1.1 -1.22 1.31 1 1
122 Tial1 NM_009383.2 II 135583291 2.02 1.54 2.12 0.0418 1
123 Bag3 NM_013863.4 II 135667130 -1.42 -1.16 -1.15 1 1
124 Inpp5f NM_178641.5 II 135754842 1.9 1.69 2.3 0.0036 1
125 Ctbp2 NM_001170744.1 II 140179304 1.22 1.15 1.33 1 1
126 LOC100043248 XM_001479821.1 II 141616800 2.49 -1.04 1.31 1 1
127 Dock1 NM_001033420.2 II 141862370 1.87 2.15 2.47 0.0384 1
128 Angiopoietin 1 NM_009640.3 III 42256273 1.05 1.01 1.66 1 1
129 Angiopoietin 2 NM_007426.3 III 18690263 -1.15 1.14 1.61 1 0.0077
130 CLIC4 NM_013885.2 III 134769884 -1.17 1.08 1.25 1 1
131 Dll4 NM_019454.2 III 119151520 1.09 1.43 1.6 1 1
132 Ephrin B2 NM_010111.5 III 8617434 1.24 1.02 1.05 1 1
133 Flk1 NM_010612.2 III 76328852 1.13 1.46 1.61 1 1
134 Flt1 NM_010228.3 III 148373180 1.15 1.86 2.15 0.2966 1
135 KLF2 NM_008452.2 III 74842932 -1.66 1.17 -1.31 1 0.8971
136 KLF4 NM_010637.3 III 55540015 -1.43 1.18 1.29 1 0.0591
137 PDGF-A NM_008808.3 III 139451968 1.43 1.11 1.29 1 1
138 PDGF-B NM_011057.3 III 79826330 -1.18 1.32 1.12 1 1
139 TGFb NM_019919.2 III 75404869 1.3 1.18 1.32 0.1245 0.0087
140 Vegfa188 NM_001025250.3 III 46153942 1.88 1.45 2.05 0.0236 1
Supplemental Table 4.1 (continued) 
113
Gene* 
number Name Accession number
Gene†
Group Start
Fold‡
E14.5
Fold‡
E16.5
Fold‡
E18.5
Bonadj§
strain
Bonadj§
Eday
141 AMPK NM_001013367.3 IV 5093861 1.35 1.3 1.69 0.4531 1
142 Ki67 NM_001081117.2 IV 142881772 1.37 1.65 1.55 0.9798 1
143 LKB1 NM_011492.3 IV 79578548 1.15 1.11 1.26 1 1
144 p16INK4a NM_009877.2 IV 88920377 1.44 1.39 1.3 1 1
145 p21 NM_007669.4 IV 29227924 1.33 1.13 1.32 1 1
146 p27 NM_009875.4 IV 134870419 1.4 1.22 1.68 0.0893 1
147 p53 NM_011640.1 IV 69393861 1.22 1.39 1.6 0.2812 1
148 PCNA NM_011045.2 IV 132074898 1.31 1.11 1.33 1 1
149 SIRT 1 NM_019812.1 IV 62781753 1.48 1.14 1.57 1 1
150 telomerase NM_009354.1 IV 73764438 3.99 2.14 3.87 0.0085 1
Supplemental Table 4.1 (continued) 
Expression assay by Nanostring nCounter.  3 RNA samples of pia at each time point for each strain, with each sample
composing of ≥ 8 embryos from ≥  2 litters.  
* Gene number same as in Figure 4.7 and Table 4.1.
†  I, genes within the EMMA region; II, gene in 95% CI of Chr 7 QTL; III, angiogentic-related genes;  IV, proliferation/aging-
related genes  
‡  Fold change for BALB/c vs B6 if positive and B6 vs BALB/c if negative. 
§ Bonferroni-adjusted p values from two-way ANOVA for strain and embryonic day.
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Figure 4.1.  Collateral extent in CXB11.HiAJ (CXB11) confirms importance of Chr 
7 QTL. A, Inheritance patterns of CXB11 (BALB/c X C57BL/6) recombinant inbred line 
(RIL) within Chr 7 QTL.  Y axis, SNP positions on Chr 7 in Build 37.  Genotypes of 
informative SNPs inherited from BALB/c (Bc) denoted in black and C57BL/6 denoted in 
grey.  CXB11 inherits the EMMA region through Itgal gene from B6 (arrows).  B, 
Collateral number is intermediate between B6 and Bc in CXB11.  C, Fractions of the 
cerebral cortex area (territories) supplied by the ACA, MCA, and PCA. B6 and Bc have 
identical territories (confirms Zhang et al. (12)), while CXB11 has slightly smaller MCA, 
larger ACA and smaller PCA territories than B6. Differences in those territories do not 
correlated with variation in collateral number or diameter in these strains.  Numbers of 
mice given in parentheses.
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Figure 4.2. Heatmap of the imputed SNPs for 74 strains within the EMMA
region. X axis, the EMMA region (p = 2.2X10-5). Abscissa, physical locations of
selective SNPs; Ordinate, 74 inbred strains. Each vertical line represents a SNP
(Blue, SNP genotype is same as in B6; Green, different from B6; Blank, genotype
unknown).
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Figure 4.3.   Collateral number for 21 inbred strains and heatmap of their SNPs 
within the EMMA region.  Left, Heatmap of known and imputed SNPs for 21 strains 
within the EMMA region (color scheme, same as Figure 4.2).   Right, collateral 
number for 21 strains.  Strain names in red denote newly phenotyped strains.  Data 
for other strains from Zhang et al.  N = 8-10/bar.  Dashed line, reference to B6.
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Figure 4.5.  Collateral extent not altered in Itgal, IL4 or IL4 receptor alpha (Ra) 
deficient mice relative to their host strains. A, Itgal -/- and IL4 -/- mice are B6 
background; IL4Ra -/- are Bc background.  Comparisons in both number and diameter 
between Itgal -/-, IL4 -/- and B6 are not significantly different, nor are those between 
IL4Ra-/- and Bc (t tests).  B, Fractions of the cerebral cortex area (territories) supplied 
by the ACA, MCA, and PCA. B6 and Bc are identical, while those in Itgal-/- and 
IL4Ra-/- differ, confirming dissociation of collateral and cerebral artery tree territory 
phenotypes among inbred mouse strains (Ref. 12).  Number of mice given in 
parentheses.    
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Figure 4.6.   Tail bleeding assays and MCA occlusion-induced cerebral infarct 
volume.  Itgal-/- and IL4-/- mice are B6 background.  Bleeding time and infarct volume 
on knockouts not different from B6; Rebleeding time in IL4-/- not different from B6, but 
shorter in Itgal-/- (t-tests). Number of mice given in parentheses.
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Supplemental Figure 4.1. Pial collateral number per hemisphere and diameter
for 21 inbred strains, including 15 strains published before (ref 12). Green bar
denotes six newly phenotyped strains. Number of animals is given at the base of each
column.
0
10
20
30
C
ol
la
te
ra
l n
um
be
r
D
ia
m
et
er
 (u
m
)
** **
*** ****** ***
***
*** ***
***
***
***
*** ** ** **
B
LK
S
FV
B
C
B
A
D
B
A
N
O
D
SJ
L
12
9S
V
B
6
N
ZW
K
K
C
3H
A/
J
AK
R
B
c
SW
R
12
9X
1
N
O
N
PW
D
LP LE
W
ES
C
as
t/E
i
0
5
10
15
** ***
*** ***
***
*,** ,*** p<0.05, 0.01, 0.001 vs B6
*
***
8     10    9      8     8     10     9     9      8  10     8     8      8    10   10 10 10 10 8      8  10  
B6
B6
122
14
0
M
b
13
0
-log10 (p)
135
4 
SN
Ps
, p
 =
  9
 X
 1
0-
6
13
2.
50
2 
–
13
2.
50
4M
b
Su
pp
le
m
en
ta
l F
ig
ur
e 
4.
2.
   
EM
M
A 
m
ap
pi
ng
 u
si
ng
 2
0 
st
ra
in
s 
ex
cl
ud
in
g 
C
as
t/E
i.
R
ed
 a
nd
 b
lu
e 
do
ts
, t
he
 m
os
t 
si
gn
ifi
ca
nt
 a
nd
 th
e 
se
co
nd
 s
ig
ni
fic
an
t S
N
Ps
 in
 th
e 
pr
ev
io
us
 E
M
M
A 
m
ap
pi
ng
 (R
ef
 3
), 
th
e 
sa
m
e 
co
lo
r s
ch
em
e 
in
 th
e 
fo
llo
w
in
g 
EM
M
A 
m
ap
pi
ng
s.
   
 A
llo
w
s 
fe
w
er
 th
an
 3
 S
N
Ps
 w
ith
 m
is
si
ng
 g
en
ot
yp
es
  
13
5
123
14
0
M
b
13
0
-log10 (p)
5 
SN
Ps
, p
 =
  9
 X
 1
0-
6
13
2.
50
2 
–
13
2.
50
4M
b
Su
pp
le
m
en
ta
l F
ig
ur
e 
4.
3.
   
EM
M
A 
m
ap
pi
ng
 u
si
ng
 1
9 
st
ra
in
s 
ex
cl
ud
in
g 
C
as
t/E
ia
nd
 P
W
D
.
Al
lo
w
s 
fe
w
er
 th
an
 3
 S
N
Ps
 
w
ith
 m
is
si
ng
 g
en
ot
yp
es
  
13
5
124
14
0
M
b
13
0
-log10 (p)
4 
SN
Ps
, p
 =
 1
.7
 X
 1
0-
5
13
2.
50
2 
–
13
2.
50
4M
b
Su
pp
le
m
en
ta
l F
ig
ur
e 
4.
4.
   
EM
M
A 
m
ap
pi
ng
 u
si
ng
 1
8 
st
ra
in
s 
ex
cl
ud
in
g 
C
as
t/E
i, 
PW
D
, a
nd
 L
EW
ES
.
Al
lo
w
s 
fe
w
er
 
th
an
 3
 S
N
Ps
 w
ith
 m
is
si
ng
 g
en
ot
yp
es
  
13
5
125
14
0
M
b
13
0
-log10 (p)
17
 S
N
Ps
, p
 =
 3
.8
 X
 1
0-
4
13
2.
49
6 
–
13
2.
50
2M
b
Su
pp
le
m
en
ta
l F
ig
ur
e 
4.
5.
   
EM
M
A 
m
ap
pi
ng
 u
si
ng
 2
1 
st
ra
in
s.
N
o 
SN
Ps
 w
ith
 m
is
si
ng
 g
en
ot
yp
es
 a
llo
w
ed
. 
13
5
126
14
0
M
b
13
0
-log10 (p)
4 
SN
Ps
, p
 <
 9
 X
 1
0-
6
13
2.
50
2 
–
13
2.
50
4M
b
Su
pp
le
m
en
ta
l F
ig
ur
e 
4.
6:
   
EM
M
A 
m
ap
pi
ng
 u
si
ng
 2
1 
st
ra
in
s 
w
ith
 o
nl
y 
in
fo
rm
at
iv
e 
SN
Ps
.
Al
lo
w
s 
fe
w
er
 th
an
 3
 S
N
Ps
 
w
ith
 m
is
si
ng
 g
en
ot
yp
es
  
13
5
127
 
 
 
 
 
 
CHAPTER V 
 
SUMMARY AND FUTURE DIRECTIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 129 
 
Summary 
 Occlusive vascular disease, including myocardial infarction, stroke, and chronic 
ischemic disease of the heart, brain and lower extremities, is the leading cause of 
morbidity and mortality in the developed countries 3, 16.  Two vascular protective 
mechanisms during ischemia have drawn much attention: the extent of native 
collaterals—the number and diameter of arteriole-to-arteriole anastomoses present in 
the tissue before the onset of disease—has  become increasingly appreciated, as well 
as their ability to remodel which has been studied for a number of years1.  These native 
collaterals not only supply blood flow immediately after occlusion, but their baseline 
number and diameter in a tissue sets the initial capacity for their remodeling/growth in 
diameter (arteriogenesis) which improves recovery of flow over the days-to-weeks after 
arterial occlusion.  Arteriogenesis describes the process of a small collateral (~30 
microns diameter in healthy tissue) increasing its anatomic diameter in 2-10 fold, thus 
growing into an artery5-8.  Since conductance is related to diameter to the fourth power, 
the resultant increases in capacity to provide flow to ischemic tissue is considerable1, 113, 
155, 156. The degree of ischemic injury is thus primarily determined by the native collateral 
extent and the amount of remodeling.  
 Many lines of evidence suggest that native collateral extent and collateral 
remodeling are subjected to the wide variation among individuals in both humans and 
inbred mice12, 24, 26, 30, 31.  Previous studies have shown that C57BL/6 (B6) and BALB/c 
(Bc) have dramatically different collateral extent and remodeling16, 34.  To dissect the 
genetic components underlying these variations, we created 243 F2s by reciprocally 
crossing B6 and Bc.  Around 10 weeks of age, a permanent MCAO was conducted in 
one side of brain in each F2 mouse.  6 days after MCAO, collateral number and 
diameter were measured in both hemispheres and DNA was prepared. 228 informative 
SNPs which evenly span the whole genome were genotyped.  Four phenotypes 
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obtained: native collateral number, average diameter, and collateral conductance 
(number X diameter) in the normal non-ligated side of brain, and fold-increase in 
diameter 6 days after MCAO were mapped to the genome, in order to identify QTL3. 
 
 
A. Chr 7 QTL predominantly determines native collateral extent 
 The collateral extent in F2s was not affected by differences in sex, parental 
origin, age, or body weight.  Mapping using both genome-wide single and multiple QTL 
models detected a major QTL on Chr 7 for three native collateral traits (number, 
diameter, and the product—an index of conductance).  In addition to Chr 7 QTL, multiple 
QTL model mapping also identified additional QTL on Chr’s 1, 3, 8 and an interaction 
between the QTL on Chr 1 and Chr 3 (LOD > 5 for all loci and the interaction).  The Chr 
7 QTL for native collateral number (designated as Canq1) alone accounts for 37% 
phenotypic variation, whereas the rest of genetic components are responsible for 35% of 
the variation.  This result establishes a predominant role of the Chr 7 QTL in determining 
native collateral number.  The peak of Chr 7 QTL is located 0.5 cM telomeric to marker 
rs13479513, with a high level of significance (134.25 Mb, p < 2X10-16).  The allele 
inherited from Bc at the position right underneath the Chr 7 QTL peak was predicted to 
reduce collateral number relative to the B6 allele.  Furthermore, I used the chromosome 
substitution strain-7, i.e., C57BL/6 mice with Chr 7 replaced by Chr 7 from the A/J strain, 
a distinct low collateral density strain, and verified the direction and effect size of the Chr 
7 QTL.  In this strain, the substitution caused most of the native collateral phenotype 
from B6-like to become A/J-like, thus confirming the predominant effect of this QTL.  
Interaction between the Chr 7 QTL and Vegfa, Clic4, or Dll4 genes, which were 
previously found to affect collateral extent1, 34, 37 was not detected by likelihood ratio 
tests3.  Importantly, the Chr 7 QTL-Canq1 is at the same locus as two previously 
 131 
 
reported QTL:  LSq-1 and Civq1.  LSq-1 was identified for both hindlimb necrosis and 
perfusion recovery 21 days after femoral artery ligation17, whereas Civq1 was detected 
for cerebral infarct volume 24 hours after MCAO18.  Both LSq-1 and Civq1 were 
identified in B6 and Bc crosses.  However, the underlying physiological mechanisms 
were not identified in these studies, owing to the complexity of the traits measured.  
Along with recent findings by Chalothorn et al.36, my results strongly suggest that 
physiological basis for these QTL is that this locus is critical in determining variation in 
native collateral number and diameter. 
 
 
B. A QTL on Chr 11 links to collateral remodeling 
 Arteriogenesis, initiated by hemodynamic changes upon occlusion, is also 
subject to variation among mouse strains12.  Although much is known about molecular 
pathways for collateral remodeling7, 8, 113, no unbiased genetic study has been conducted 
to identify underlying risk factors.  Fold increase in collateral diameter 6 days after 
MCAO, a parameter indicating collateral outward growth, was also mapped in B6 X Bc 
F2s.  As expected, a QTL on Chr 7 again was identified to be associated with collateral 
remodeling.  As noted before, the remodeling process is stimulated by shear stress.  
And shear stress is negatively correlated to native collateral diameter157.  Thus, it is not 
surprise that remodeling has a same QTL on Chr 7 as native collateral diameter does.  
When native collateral diameter was set as a covariate in the subsequent mapping, Chr 
7 QTL disappeared.  Instead, a new significant QTL on Chr 11 was obtained: Carq1.  
Although the effect size for this QTL is small, this finding is the first time to directly show 
a genetic component underlying the remodeling3.  Interestingly, the studies cited above 
only found the Chr7 QTL for response to ischemic injury, but failed to identify Carq117, 158.   
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C. Association mapping narrows down the candidate genetic elements in the Chr 
7 QTL              
 Association mapping in inbred mice, previously termed in silico mapping, was 
first proposed by Grupe et al76.   However, along with haplotype association mapping, 
this approach has been criticized primarily because of high false-positives due to limited 
sample sizes and the relatedness embedded among inbred strains74, 75, 77, 79.  Two 
previous studies related to ischemic injury employed interval-specific SNP haplotype 
association mapping in which only 3 or 4 strains were used17, 18.   Here, I confined 
association mapping only within the Chr 7 QTL and applied the efficient mixed model 
association (EMMA) algorithm in which the relatedness among 15 classical inbred 
strains was accounted for by a kinship matrix3, 79.  The most significant 172kb region (p = 
2.2 X 10-5), designated as the EMMA region hereafter, and a second most significant 
region (p = 4.2 X 10-4) adjacent to the first, were obtained by EMMA mapping using data 
that was previously obtained for native collateral number for the 15 strains3, 12.    
 To verify and possibly narrow down the EMMA region, I employed a novel 
strategy:  Using a heat map approach, I visualized SNP variation within the most 
significant EMMA region for 74 inbred strains, employing known and high quality 
imputed genotypes.  Using this visualization, I chose 6 inbred strains judged to be 
informative by their similarities in haplotype structure within the EMMA region to that in 
B6-high collateral density strain or that in Bc–low density strain.  Four of six strains fit the 
expectation by their haplotype similarities: 129X1/Sv, NON/ShiLt, LP, and LEWES/Ei 
(Chapter IV).  Two strains - Cast/Ei and PWD that did not fit the expectation are wild-
derived strains.  Recent studies suggested that these two strains share < 3% haplotype 
ancestral origins with classical inbred strains151, 152, 159.  On the other hand, LEWES, also 
a wild-derived strain, has few collaterals—as predicted by its haplotype structure.   
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Results from a study that densely genotyped SNPs for 94 inbred strains suggest that 
LEWES shares more haplotype ancestral origins with classical inbred strains than do 
Cast/Ei or PWD150.   Further EMMA mapping for collateral number using these six 
strains along with the previous 15 strains refined the previous most significant region 
and narrowed it to several SNPs (Chapter IV). 
 
 
D. Collateral extent in knockout mice argues against a role for Itgal or IL4-
receptor-α 
 To identify which genes govern native collateral extent, we examined gene-
deleted mice for three candidate genes, Itgal-/- and IL4-/- on the B6 background and 
IL4ra-/- on the Bc background.  All three had similar pial collateral extents as their 
respective host strains.  This finding argues against the notation that these three genes 
harbor causal alleles for collateral variation.  We further examined infarct volume after 
MCAO-induced ischemic injury in Itgal-/- and IL4-/- mice.  The results indicated that these 
gene-deletion mice also have similar infarct volume as their host strains.  This result is 
consistent with our findings of collateral extent and argues against a regulatory role of 
these two genes (Chapter IV).   However, knockout strategies have limitations.  For 
instance, knockout strains are usually made in X129 embryonic stem cells.  The 
resulting mice are then bred back to the desired strain for 6-10 generations.  The 
backcross leaves an island of X129 DNA at the site of the mutated gene that, 
theoretically, can have confounding effects from incorporated neighboring X129 genes.  
Limitations in conclusions can also arise from potential compensation due to deletion.  
Moreover, gene deletion does not test for an allele change that causes a new function 
on one of the respective backgrounds.   Nevertheless, gene-deleted mice remain an 
important approach to examine candidate genes160.      
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E. mRNA quantification of genes within the 95% CI of Canq1 identifies high 
priority genes 
 Using the cerebral pial collateral circulation as a model, Chalothorn et al. 
discovered that collaterals begin forming at ~E14.5 and peak in number at ~ E18.5 in 
both B6 and Bc38.  Furthermore, he found that differences in extent of the collateral 
circulation in adults are primarily determined during collateral formation in the embryo38, 
although processes governing stabilization of nascent collaterals in the first few weeks of 
life and maintenance of them during growth to adulthood also contribute161.  Therefore, I 
dissected the pial membrane containing the dorsal cortical pial circulation from B6 and 
Bc at E14.5, E16.5 and E18.5 when the collateral circulation is forming.  At each time 
point for each strain, three RNA samples were prepared with each from at least 8 
embryos derived from at least 2 litters.  I then measured expression of 150 genes 
comprised of 120 genes within 95% CI of Canq1, plus angiogenic-related, 
proliferation/aging-related genes.  Among the 120 genes, 19 were expressed 
differentially between B6 and Bc, with 9 consistently more than 2-fold higher in Bc than 
in B6 at each time-point.   One gene, Pycard, was expressed at least 60% higher in B6 
at all time-points.  Nsmce1 (132.6 Mb), located in the second significant EMMA region 
(132.53 - 132.82 Mb), has three splicing isoforms, two of which express at least 2-fold 
higher in Bc (Chapter IV).      
 
 
Future Directions 
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F. A new F2 cross—SWR X SJL—to identify genetic components regulating 
collateral extent  
 My EMMA mapping identified the SJL strain as an outlier:  SJL and SWR share 
the same genotypes for the most significant SNPs within the EMMA region.  However, 
SJL averages 9.6 pial collaterals while SWR has 1.3 (Figure 4.3).  Thus, what genetic 
components are responsible for the variation in collateral number between these two 
strains?  We hypothesized that the genetic architecture underlying variation in collateral 
number between SJL and SWR is different from that between B6 and Bc.  To test this 
hypothesis, I created 125 F2 crossed between SJL X SWR.  For each mouse at ~10 
weeks of age, we filled the pial circulation with Microfil and counted pial collateral 
number microscopically following the procedures described before3, 12.  The genotypes of 
1449 SNPs across the genome for each mouse were obtained using the GoldenGate 
middle density linkage array.  Linkage analysis and association mapping to identify 
underlying novel genetic components is currently underway.   
 
 
G. advanced search for genetic sources of variation in collateral formation in the 
mouse as a model for man 
 The Collaborative Cross (CC) is a large panel of recombinant inbred lines 
(RILs) derived from a genetically diverse set of founders 162-164 that could be applied to 
future extension of my findings.  The CC, which is being completed through efforts at 
several centers around the world including UNC, will provide a unique and powerful 
resource for functional studies of biological networks that will be essential for 
understanding the mechanisms of many diseases163.  The eight founders consist of five 
classical inbred strains (A/J, C57BL/6J, 129S1/SvImJ, NOD/LtJ, NZO/H1LtJ) and three 
wild-derived strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ).  These strains are predicted to 
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capture on average 89% of the known allelic diversity in the mouse genome 108.  We 
have already phenotyped 4/5 classical and 1/3 wild-derived strains for collateral extent, 
with a good distribution of differences in collateral number and diameter that the three 
additional strains will likely enhance.     
 As reported by the latest review for the CC, ~500 eight-way RI lines are extant, 
with the goal of eventually acquiring ~1000 lines162.    Compared to other genetic 
sources such as traditional recombinant inbred lines from two progenitors, congenic 
strains, chromosome substitution strains, heterogeneous stocks, and the mouse 
phenotype diversity panel, the CC has multiple advantages108:  (1) The CC incorporates 
a large amount of variation, with the distribution of minor allele frequency approximating 
that in human.  For example, CXB RILs only capture 14% variation while the CC 
captures 89% of the variation in the mouse genome108.  Conducting association mapping 
for collateral extent in the CC will likely allow us to identify many novel genetic 
components because of the diverse genetic variation; (2) The CC provides association 
mapping with a larger sample size and better precision.  While association mapping for 
collateral extent in the CC can identify loci more relevant to human population, the 
sufficient sample size (up to 1000 RILs) can also achieve better statistical power:  500 
RILs can detect a QTL having 5% genetic effect with power of 0.67 and precision of 0.96 
cM 165, 166.  With such a precision and power, one can predict that the Chr 7 QTL, with its 
large effect, will be narrowed down to the 1-2 gene level.  And many QTL with small 
effects can be detected with better resolution;  (3) In addition, the CC offers 
reproducibility and cost efficiency.  Unlike F2s, unlimited mice with identical genetic 
background for each line are available in the CC163.  This feature is especially important 
in searching for genes governing collateral extent.  For example, it is not possible to 
extract enough RNA from collaterals in the pial circulation of a single mouse for 
expression analysis.  Moreover, filling the pial collaterals with yellow Microfil, required for 
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phenotyping, is not compatible with RNA extraction in the same mouse.   This technical 
difficulty greatly limits our capability to identify candidate genes:  It eliminates genome-
wide expression-QTL (eQTL), systems genetics and causality analyses.  With the CC, 
we could dissect individual pial collaterals (10-40um diameter X 100-300um length) in 
multiple mice from each line, as well as phenotype multiple mice in a second group of 
the same line.   This would allow us to perform, for example, expression QTL mapping.  
Here, cis expression QTL (eQTL), defined as cis-eQTL with mapping position nearby 
and proximal to a given gene’s location, can be used to prioritize the candidate genes for 
a QTL in linkage analysis.  Combining gene expression data and collateral extent with 
genotypic data would permit performance of causal inference analysis to identify the 
underlying genes responsible for variation in collateral extent 110, 167, 168, i.e., those genes 
that control the process of collateral formation.  Furthermore, the CC is cost-efficient 
because the genotypes of the dense SNPs for all RILs in the cross are already known162.  
 
 
H. Detailed mapping of the genetic architecture of collateral remodeling 
 In their study, Dokun et al. reported an identical QTL on chromosome 7 for 
recovery of flow (LOD= 3.71, p= 0.05) and tissue necrosis score (LOD = 7.96, p = 0.001) 
after femoral artery ligation (FAL) in a B6 X Bc mapping population.  The recovery of 
flow and tissue necrosis score at day 7, 14, and 21 after FAL are largely dependent on 
collateral number, diameter, and outwards remodeling.  Since collateral extent and 
remodeling were not quantified in this study, the underlying physiological mechanisms 
were not revealed.  Wang et al. identified a highly significant QTL at the same locus for 
pial collateral traits: number, diameter, and conductance in 243 B6 X Bc F2s.  
Subsequent multi-QTL mapping showed that native (baseline) diameter is a major 
determinant of collateral remodeling.  This is in agreement with the well-known fact that 
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shear-stress varies by diameter-cubed, and that the shear stress applied to collateral 
endothelial cells after artery obstruction is the initiating stimulus and major subsequent 
driving stimulus for the biological program governing collateral remodeling.  This implies 
that loci governing variation in baseline collateral diameter (I found one with the same 
locus as for number on chromosome 7, i.e., Cadq1) will be, indirectly, major 
determinants of variation in collateral remodeling.  However, multi-QTL mapping with 
baseline diameter treated as a co-variate, identified a barely significant QTL on Chr 11 
for collateral remodeling independent of initial diameter3.  This finding is particularly 
promising, because it was derived from a cross that other work in the lab has now shown 
that the two strains are not optimal parentals to map remodeling trait.  Zhang et al (2010) 
showed that remodeling of pial collaterals is only slightly weaker in Bc compared to B6.   
In contrast, A/J are 3-fold stronger than B6, a finding recently confirmed in hindlimb 
collaterals by Chalothorn et al36.  Taken together, these findings indicate that variation in 
collateral remodeling is not only governed by baseline diameter, but also by genetic 
elements distinct from those that specify native diameter.  Zhang et al. also measured 
pial collateral outward remodeling in 12 additional strains.  While they found that B6 and 
Bc have similar fold-change in diameter (~1.8), remodeling in SWR is ~5-fold stronger 
than that in Bc and the strongest among all 15 strains studied.  Indeed, the rank order of 
collateral number and diameter are distinct from that for remodeling among the 15 
strains.  These results partially explain why we found a barely significant but distinct QTL 
on Chr 11 for remodeling.  As suggested by many lines of evidence, collateral 
remodeling is subject to variation 12, 89, 156.  The phenotypic variation between parentals in 
a segregating population will greatly affect the power to detect QTL (Churchill, 2007).  To 
map the genetic components underlying collateral remodeling, a mapping population of 
Bc X SWR would be predicted to be much more likely to confirm, with a higher LOD 
score, the Chr 11 QTL for remodeling, as well as to identify additional QTL independent 
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of native collateral diameter, since diameter and number are comparable in these two 
strains12.  
 
  
I. Identify additional low-collateral-density strains  
 Our ability to identify the genetic source of variation in collateral number, the 
most important determinant of tissue injury in occlusive diseases, is greatly impaired by 
few low-collateral-density strains.  Among 21 strains phenotyped for collateral extent, 
only 6 strains are significantly lower than B6 in number (and none is significantly higher).  
All of these strains originated from the Mus domesticus subspecies, allowing us to 
postulate that the variant we identified on Chr 7 QTL arose as a mutation during the 
history of generation of the classical inbred strains in the past 100 years159, 169.  We 
hasten to point out here, as we discussed in Chapter I, that wide variation in native 
collateral extent also appears to exist in the healthy human population24.  The heatmap 
representation (Chapter IV), which facilitates choosing informative strains, is convenient 
to construct.  However, it lacks strength for haplotype inference and did not prove perfect 
for predicting collateral phenotype.  To identify more strains with low collateral density, 
ancestral haplotype origins for inbred strains need to be inferred, especially for strains 
originating from Mus domesticus.  
 Wade et al.159 observed high SNP-rate (~40 SNPs/10 kb) and low SNP-rate 
(~0.5 SNPs/10 kb) regions alternatively within the genome of most inbred strains, using 
strain-strain pair-wise comparisons169.  The high SNP-rate regions cover one third of the 
genome on average.  An ancestry breakpoint was defined as a location at which any of 
the pairwise comparisons transited from a low SNP-rate to a high SNP-rate region.  
Therefore, the ancestral haplotype can be inferred using this approach.  Further, they 
showed that positional cloning of a region identified in a QTL mapping study can be 
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efficiently obtained by correlating phenotypes with ancestral haplotypes.  As an example, 
genetic components for albinism were quickly narrowed to a 500kb region close to the 
tyrosinase gene using this method169.  Two subsequent studies utilized SNP data from 
the 15 strain re-sequencd data by Perlegen to infer the ancestral haplotype origins for 
several classical inbred strains using Hidden Markov Model (HMM)151, 152.  Both studies 
found that the classical inbred strains inherited the majority of their genomes from Mus 
domesticus.  To infer ancestral haplotype origins, the genotypes for dense SNPs are 
needed for more inbred strains.  A recent study by Kirby et al. expanded this effort and 
genotyped 121,000 SNPs for 94 inbred strains, with SNPs dispersing at 20kb interval on 
average across the genome150.  Since the major source of genetic variation governing 
collateral extent may have arisen during the generation of classical inbred strains, one 
novel approach going forward would be to select classical inbred strains different from 
the 21 we’ve studied and to infer their ancestral haplotype origins based on the dense 
SNPs within the Chr 7 QTL published by Kirby et al150.  A proposed study is to choose 
non-wild-derived inbred lines among the 94 densely genotyped strains.  High SNP-rate 
and low SNP-rate regions can then be inferred in pairwise strain-strain comparisons 
using the HMM algorithm.  Haplotype structure can then be inferred by defining ancestry 
break points among any of the pairwise comparisons.  Based on the inferred haplotype 
structure, one can then identify predicted low-collateral-density strains to phenotype.   
 Given the high prevalence of arterial obstructive disease, a therapeutic 
compound to stimulate new collateral vessel formation or enlargement of the diameter of 
the native population in adults could have a major impact on morbidity and mortality.   
Although results from animal studies over the past 10 years have held promise for 
various agents to stimulate arteriogenesis, not a single drug has proved applicable in 
clinical practice thus far, either because of lack of efficacy (due to either poor response 
or high variability in response) or because of undesired side effects170.  If the causal 
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gene(s) or genetic element(s) for the Chr 7 QTL can be identified, the orthologous loci in 
the human could then be tested as both biomarkers for collateral extent and assignment 
of risk-severity for stroke, myocardial infarction, peripheral artery disease and other 
obstructive conditions.  Such a biomarker(s) would also allow patients to be stratified in 
trials of new proposed collateralogenic therapies, thus reducing the variation in the test 
population by assigning patients to low and high collateral extent groups.  Moreover, 
discovering these variants would, by definition, point to the signaling molecules 
responsible for formation of these unique vessels in the embryo.  This information would 
then permit a rational approach to developing therapies aimed at re-activating this 
developmental process in adult tissues.  
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